CN113215117B - Duck tembusu virus attenuated live vaccine candidate strain and preparation method and application thereof - Google Patents
Duck tembusu virus attenuated live vaccine candidate strain and preparation method and application thereof Download PDFInfo
- Publication number
- CN113215117B CN113215117B CN202110533162.1A CN202110533162A CN113215117B CN 113215117 B CN113215117 B CN 113215117B CN 202110533162 A CN202110533162 A CN 202110533162A CN 113215117 B CN113215117 B CN 113215117B
- Authority
- CN
- China
- Prior art keywords
- duck tembusu
- strain
- virus
- duck
- virus strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000686770 Duck Tembusu virus Species 0.000 title claims abstract description 37
- 230000002238 attenuated effect Effects 0.000 title claims abstract description 18
- 229940125575 vaccine candidate Drugs 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title claims description 4
- 241000700605 Viruses Species 0.000 claims abstract description 102
- 241000272525 Anas platyrhynchos Species 0.000 claims abstract description 98
- 240000000915 Fagraea fragrans Species 0.000 claims abstract description 77
- 229960005486 vaccine Drugs 0.000 claims abstract description 14
- 108090000565 Capsid Proteins Proteins 0.000 claims abstract description 13
- 102100023321 Ceruloplasmin Human genes 0.000 claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 13
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 13
- 238000012224 gene deletion Methods 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 230000003053 immunization Effects 0.000 abstract description 19
- 238000002649 immunization Methods 0.000 abstract description 18
- 230000003313 weakening effect Effects 0.000 abstract description 18
- 230000035772 mutation Effects 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 12
- 230000007246 mechanism Effects 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 9
- 230000007547 defect Effects 0.000 abstract description 7
- 210000000987 immune system Anatomy 0.000 abstract description 4
- 230000010464 virion assembly Effects 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 21
- 239000012634 fragment Substances 0.000 description 18
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 17
- 208000015181 infectious disease Diseases 0.000 description 16
- 210000002257 embryonic structure Anatomy 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 10
- 206010058874 Viraemia Diseases 0.000 description 10
- 210000002845 virion Anatomy 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000001018 virulence Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 241000272522 Anas Species 0.000 description 5
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 5
- 230000002458 infectious effect Effects 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 102100026720 Interferon beta Human genes 0.000 description 4
- 108010047761 Interferon-alpha Proteins 0.000 description 4
- 102000006992 Interferon-alpha Human genes 0.000 description 4
- 108090000467 Interferon-beta Proteins 0.000 description 4
- 102000004388 Interleukin-4 Human genes 0.000 description 4
- 108090000978 Interleukin-4 Proteins 0.000 description 4
- 101800004937 Protein C Proteins 0.000 description 4
- 102000017975 Protein C Human genes 0.000 description 4
- 101800001700 Saposin-D Proteins 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 229960000856 protein c Drugs 0.000 description 4
- 101710117545 C protein Proteins 0.000 description 3
- 241000710831 Flavivirus Species 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 230000007969 cellular immunity Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 229940031551 inactivated vaccine Drugs 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940031567 attenuated vaccine Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000234 capsid Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000010726 hind limb paralysis Diseases 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 229940124590 live attenuated vaccine Drugs 0.000 description 2
- 229940023012 live-attenuated vaccine Drugs 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- -1 IL-1β Chemical compound 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 208000005963 oophoritis Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
- C12N2770/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24162—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明中公开了一种鸭坦布苏病毒致弱活疫苗候选株,该候选株为鸭坦布苏ΔC64‑96突变病毒株,所述鸭坦布苏ΔC64‑96突变病毒株为基因缺失突变病毒株,其缺失的基因序列为编码鸭坦布苏病毒Capsid蛋白第64位‑第96位氨基酸的核苷酸序列。该致弱活疫苗候选株在病毒粒子的装配过程中存在缺陷,导致病毒致弱,其致弱机制被清楚解析,有效提高疫苗的使用安全性;且该致弱活疫苗候选株对雏鸭的单次免疫就能显著激活受感染雏鸭的免疫系统,且能提供强有效的免疫保护效果。
The present invention discloses a candidate strain of duck tembusu virus attenuated live vaccine, the candidate strain is duck tembusu ΔC64-96 mutant virus strain, and the duck tembusu ΔC64-96 mutant virus strain is a gene deletion mutation A virus strain whose deleted gene sequence is the nucleotide sequence encoding the amino acids 64-96 of the Capsid protein of duck Tembusu virus. The attenuated live vaccine candidate strain has defects in the virion assembly process, which leads to the weakening of the virus, and its weakening mechanism has been clearly analyzed, which effectively improves the safety of the vaccine; A single immunization can significantly activate the immune system of infected ducklings and provide strong and effective immune protection.
Description
技术领域technical field
本发明涉及生物工程技术领域,尤其涉及一种鸭坦布苏病毒致弱活疫苗候选株及其制备方法和应用。The invention relates to the technical field of bioengineering, in particular to a candidate strain of duck Tembusu virus attenuated live vaccine and a preparation method and application thereof.
背景技术Background technique
鸭坦布苏病毒病自2010年在中国东南沿海地区首次爆发以来,迅速扩散大到全国多个省市,给我国的养鸭产业造成了巨大的经济损失。鸭坦布苏病是一种以蛋鸭、种鸭产蛋骤然大幅下降为主要临床特征、以出血性卵巢炎为主要病变特征的急性传染病。当前对该病的防控措施尚不完善,虽然已有商品化的减毒活疫苗和灭活疫苗,但目前该病仍呈现地区性流。已有的商品化灭活疫苗安全性较高,但是灭活疫苗的生产成本高,对运输、保存条件要求严格,且免疫效果不够理想,需要多次增强免疫,加大了鸭群的应激反应。而现有的减毒活疫苗都是通过传统连续传代,使病毒在适应异源宿主细胞过程中产生适应性突变,最终获得减毒的具有免疫原性的表型。这种方式获得的减毒的疫苗候选株的病毒致弱分子机制不清楚,或是未完全解析清楚;由于缺少对其详细的机制的了解,将限制对其自然回复到强毒表型的风险的评估,因此安全风险较高。所以,当前的DTMUV的疫苗仍有很大的提高空间,尤其需要研制一种安全性高、免疫效果好的DTMUV疫苗。Since the first outbreak of duck Tembusu virus disease in the southeastern coastal areas of China in 2010, it has rapidly spread to many provinces and cities across the country, causing huge economic losses to my country's duck industry. Duck Tembusu disease is an acute infectious disease characterized by a sudden and sharp drop in egg production in laying ducks and breeding ducks, and hemorrhagic oophoritis as the main lesion. At present, the prevention and control measures of the disease are not perfect. Although there are commercialized live attenuated vaccines and inactivated vaccines, the disease is still showing a regional trend. The existing commercial inactivated vaccines are relatively safe, but the production cost of inactivated vaccines is high, the transportation and storage conditions are strict, and the immunization effect is not ideal. reaction. However, the existing live attenuated vaccines are all traditionally serially passaged, so that the virus produces adaptive mutations in the process of adapting to heterologous host cells, and finally obtains an attenuated immunogenic phenotype. The molecular mechanisms of virus attenuating of the attenuated vaccine candidates obtained in this way are unclear or not fully resolved; the lack of understanding of their detailed mechanisms will limit the risk of their natural reversion to a virulent phenotype assessment, and therefore a higher security risk. Therefore, the current DTMUV vaccine still has a lot of room for improvement, and it is especially necessary to develop a DTMUV vaccine with high safety and good immune effect.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于解决现有技术存在的鸭坦布苏病毒减毒疫苗安全性低,免疫效果不理想的问题,提供一种鸭坦布苏病毒致弱活疫苗候选株,该候选株为鸭坦布苏ΔC64-96突变病毒株,鸭坦布苏ΔC64-96突变病毒株在病毒粒子的装配过程中存在缺陷,导致病毒致弱,其致弱机制被清楚解析,有效提高该致弱活疫苗候选株的使用安全性;且鸭坦布苏ΔC64-96突变病毒株对雏鸭的单次免疫就能显著激活受免疫雏鸭的免疫系统,极大提高免疫效果。The purpose of the present invention is to solve the problems of low safety and unsatisfactory immune effect of the duck Tembusu virus attenuated vaccine existing in the prior art, and to provide a duck Tembusu virus attenuated live vaccine candidate strain, and the candidate strain is a duck Tembusu ΔC64-96 mutant virus strain, duck Tembusu ΔC64-96 mutant virus strain has defects in the assembly process of virions, resulting in weakening of the virus, and its weakening mechanism has been clearly analyzed, effectively improving the weakening of live vaccine The use of the candidate strain is safe; and a single immunization of ducklings with the duck Tembusu ΔC64-96 mutant virus strain can significantly activate the immune system of the immunized ducklings and greatly improve the immune effect.
为解决上述技术问题,本发明采用的技术方案如下:一种鸭坦布苏病毒致弱活疫苗候选株,该候选株为鸭坦布苏ΔC64-96突变病毒株,所述鸭坦布苏ΔC64-96突变病毒株为基因缺失突变病毒株,其缺失的基因序列为编码鸭坦布苏病毒Capsid蛋白第64位-第96位氨基酸的核苷酸序列。In order to solve the above-mentioned technical problems, the technical solution adopted in the present invention is as follows: a candidate strain of a duck tembusu virus attenuated live vaccine, the candidate strain is a duck tembusu ΔC64-96 mutant virus strain, and the duck tembusu ΔC64 The -96 mutant virus strain is a gene deletion mutant virus strain, and the deleted gene sequence is the nucleotide sequence encoding amino acids 64-96 of Capsid protein of duck Tembusu virus.
本发明还提供上述鸭坦布苏致弱活疫苗候选株的制备方法,,包括以下步骤:The present invention also provides a method for preparing the above-mentioned candidate strain of the duck tembusu attenuated live vaccine, comprising the following steps:
S1、以鸭坦布苏病毒株DTMUV-CQW1株的pACNR-FL-CQW1质粒为模板,以序列SEQ IDNO.1和SEQ ID NO.2为引物,PCR扩增得到片段P1;以序列SEQ ID NO.3和SEQ ID NO.4为引物,PCR扩增得到片段P2;再以片段P1和片段P2为模板,以序列SEQ ID NO.1和SEQ ID NO.4为引物,通过融合PCR扩增得到基因缺失突变的片段P1P2,所述片段P1P2缺失的基因序列为编码鸭坦布苏病毒的Capsid蛋白第64位-第96位氨基酸的核苷酸序列;S1. Using the pACNR-FL-CQW1 plasmid of the duck Tembusu virus strain DTMUV-CQW1 as a template, and using the sequences of SEQ ID NO.1 and SEQ ID NO.2 as primers, PCR amplification was performed to obtain fragment P1; .3 and SEQ ID NO.4 are primers, and PCR amplification obtains fragment P2; then take fragment P1 and fragment P2 as templates, take sequence SEQ ID NO.1 and SEQ ID NO.4 as primers, and obtain by fusion PCR amplification The fragment P1P2 of the gene deletion mutation, the gene sequence of the fragment P1P2 deletion is the nucleotide sequence encoding the 64th-96th amino acid of the Capsid protein of duck Tembusu virus;
S2、将pACNR-FL-CQW1质粒用限制性内切酶MluI和XhoI进行双酶切,并回收纯化,获得纯化的线性pACNR-FL-CQW1质粒载体;S2. The pACNR-FL-CQW1 plasmid is double digested with restriction enzymes MluI and XhoI, and recovered and purified to obtain a purified linear pACNR-FL-CQW1 plasmid vector;
S3、将步骤S1中的基因片段P1P2与步骤S2中的纯化的线性pACNR-FL-CQW1质粒载体进行重组连接,然后转化大肠杆菌感受态细胞,挑选阳性菌落测序鉴定,获得重组质粒,并命名为pACNR-FL-CQW1-ΔC64-96质粒;S3. Recombinantly connect the gene fragment P1P2 in step S1 with the purified linear pACNR-FL-CQW1 plasmid vector in step S2, then transform E. coli competent cells, select positive colonies for sequencing and identification, and obtain a recombinant plasmid, which is named as pACNR-FL-CQW1-ΔC64-96 plasmid;
S4、将步骤S3中的pACNR-FL-CQW1-ΔC64-96质粒转染BHK21细胞,培养5天后收获上清液,即获得鸭坦布苏ΔC64-96突变病毒株。S4. The pACNR-FL-CQW1-ΔC64-96 plasmid in step S3 was transfected into BHK21 cells, and the supernatant was harvested after culturing for 5 days to obtain the duck tembusu ΔC64-96 mutant virus strain.
优选地,所述片段P1的核苷酸序列如SEQ ID NO.5所示;所述片段P2的核苷酸序列如SEQ ID NO.6所示;所述片段P1P2的核苷酸序列如SEQ ID NO.7所示;所述pACNR-FL-CQW1-ΔC64-96质粒的序列如SEQ ID NO.8所示。Preferably, the nucleotide sequence of the fragment P1 is shown in SEQ ID NO. 5; the nucleotide sequence of the fragment P2 is shown in SEQ ID NO. 6; the nucleotide sequence of the fragment P1P2 is shown in SEQ ID NO. ID NO.7; the sequence of the pACNR-FL-CQW1-ΔC64-96 plasmid is shown in SEQ ID NO.8.
优选地,所述PCR扩增的条件为:95℃预变性1min;95℃变性15s,63℃退火15s,72℃延伸15s/kb,共30个循环;最后72℃后延伸7min。Preferably, the PCR amplification conditions are: pre-denaturation at 95°C for 1 min; denaturation at 95°C for 15s, annealing at 63°C for 15s, extension at 72°C for 15s/kb, a total of 30 cycles; and a final extension at 72°C for 7 min.
将通过上述方法制备得到的鸭坦布苏致弱活疫苗候选株制备成鸭坦布苏病毒致弱活疫苗免疫雏鸭,能为雏鸭带来安全且高效的免疫保护。The duck Tembusu attenuated live vaccine candidate strain prepared by the above method is prepared into ducklings immunized with duck Tembusu virus attenuated live vaccine, which can bring safe and efficient immune protection to the ducklings.
Capsid(C)蛋白是黄病毒的最小的结构蛋白,经NS2B3蛋白酶切割后产生的成熟C蛋白只有100氨基酸左右。C蛋白结构与功能在黄病毒属中高度保守,其结构包含4个α螺旋,会通过疏水相互作用、氢键等力形成二聚体。C蛋白最重要的功能是通过二聚体结构结合病毒基因组RNA(vRNA),形成Nucleocapsid(NC)参与病毒粒子的组装,NC在出芽获得病毒囊膜后形成完整的病毒粒子(Virion)。对黄病毒研究发现,C蛋白能容受较大程度的截短突变仍保持病毒的感染性,但会导致亚病毒颗粒(Subviral particles,SVPs)的产量增加。SVPs不含NC,但是构象和免疫原性与virion十分相似,是良好的免疫原。因此,C蛋白是病毒致弱的理想靶标。而本发明中的鸭坦布苏ΔC64-96突变病毒株经基因缺失突变获得,其缺失了编码鸭坦布苏病毒Capsid蛋白第64位-第96位氨基酸的核苷酸序列,因此,鸭坦布苏ΔC64-96突变病毒株无法表达Capsid蛋白第64位-第96位氨基酸,这种删除突变直接影响了病毒粒子的组装过程,从而造成鸭坦布苏ΔC64-96突变病毒株致弱。Capsid (C) protein is the smallest structural protein of flavivirus, and the mature C protein produced by NS2B3 protease cleavage is only about 100 amino acids. The structure and function of protein C are highly conserved among flaviviruses, and its structure contains four α-helices, which can form dimers through hydrophobic interactions, hydrogen bonds, and other forces. The most important function of protein C is to bind viral genomic RNA (vRNA) through a dimer structure to form Nucleocapsid (NC) and participate in the assembly of virions. NC forms complete virions (Virion) after budding to obtain the viral envelope. Studies on flaviviruses have found that protein C can tolerate a greater degree of truncation mutation and still maintain the infectivity of the virus, but it will lead to an increase in the production of subviral particles (SVPs). SVPs do not contain NC, but their conformation and immunogenicity are very similar to virion, making them good immunogens. Therefore, protein C is an ideal target for viral attenuation. The duck tembusu ΔC64-96 mutant virus strain in the present invention is obtained by gene deletion mutation, and it lacks the nucleotide sequence encoding the 64th-96th amino acids of the duck tembusu virus Capsid protein. The Busu ΔC64-96 mutant strain could not express amino acids 64-96 of the Capsid protein. This deletion mutation directly affected the assembly process of the virion, resulting in the weakening of the duck Tembusu ΔC64-96 mutant strain.
本发明所具有的有益效果:The beneficial effects that the present invention has:
一)本发明中删除了编码鸭坦布苏病毒Capsid蛋白第64位-第96位氨基酸的核苷酸序列,使Capsid蛋白第64位-第96位氨基酸缺失,获得鸭坦布苏ΔC64-96突变病毒株。1) In the present invention, the nucleotide sequence encoding the 64th-96th amino acid of the Capsid protein of duck Tembusu virus is deleted, and the 64th-96th amino acid of the Capsid protein is deleted to obtain duck tembusu ΔC64-96 mutant virus strains.
二)本发明中的鸭坦布苏ΔC64-96突变病毒株的致弱机制被清楚解析,该突变病毒株在病毒粒子的组装过程中存在明显缺陷,降低了打包复制子RNA的能力,从而使突变病毒株致弱,显著降低病毒对鸭胚和雏鸭的毒力;而且该突变病毒株具有遗传稳定性,因此将鸭坦布苏ΔC64-96突变病毒株制备成鸭坦布苏病毒致弱活疫苗免疫雏鸭,能有效提高疫苗使用的安全性。2) The weakening mechanism of the duck Tembusu ΔC64-96 mutant virus strain in the present invention is clearly analyzed, and the mutant virus strain has obvious defects in the assembly process of the virion, which reduces the ability to package the replicon RNA, thereby making the The weakening of the mutant virus strain significantly reduces the virulence of the virus to duck embryos and ducklings; and the mutant virus strain is genetically stable, so the duck Tembusu ΔC64-96 mutant virus strain was prepared into a weakened duck Tembusu virus. Immunizing ducklings with live vaccines can effectively improve the safety of vaccine use.
三)本发明中鸭坦布苏ΔC64-96突变病毒株能显著激活被免疫雏鸭的免疫系统,使多个免疫相关细胞因子的表达水平显著上调,且单次免疫后即能为雏鸭提供完全的攻毒保护效果,因此,鸭坦布苏ΔC64-96突变病毒株是一株安全且高效的致弱活疫苗候选病毒株。3) The duck Tembusu ΔC64-96 mutant virus strain in the present invention can significantly activate the immune system of the immunized ducklings, significantly up-regulate the expression levels of multiple immune-related cytokines, and can provide the ducklings after a single immunization. Complete challenge protection effect, therefore, duck Tembusu ΔC64-96 mutant virus strain is a safe and efficient attenuated live vaccine candidate virus strain.
附图说明Description of drawings
图1为pACNR-FL-CQW1质粒图谱;Fig. 1 is the plasmid map of pACNR-FL-CQW1;
图2为pACNR-FL-CQW1-ΔC64-96质粒感染性克隆构建示意图;Figure 2 is a schematic diagram of the construction of an infectious clone of the pACNR-FL-CQW1-ΔC64-96 plasmid;
图3为实施例2中鸭坦布苏ΔC64-96突变病毒株转染BHK21细胞后F0代和F1代的荧光信号图;Figure 3 is a graph of the fluorescence signals of the F0 and F1 generations after the duck Tembusu ΔC64-96 mutant virus strain was transfected into BHK21 cells in Example 2;
图4为实施例3中鸭坦布苏ΔC64-96突变病毒株在BHK21细胞上的生长曲线图;Fig. 4 is the growth curve diagram of duck Tembusu ΔC64-96 mutant virus strain on BHK21 cells in Example 3;
图5为实施例3中鸭坦布苏ΔC64-96突变病毒株的F1代和F10代的噬斑试验结果图;5 is a graph showing the plaque test results of the F1 generation and the F10 generation of the duck Tembusu ΔC64-96 mutant virus strain in Example 3;
图6为实施例3中鸭坦布苏ΔC64-96突变病毒株的病毒包装试验结果图(图6A为反式互补的包装系统图,图6BΔC64-96缺失突变对病毒包装的影响图)Figure 6 is a graph showing the results of the virus packaging test of the duck Tembusu ΔC64-96 mutant virus strain in Example 3 (Fig. 6A is a diagram of a trans-complementary packaging system, and Fig. 6B is a graph of the effect of the ΔC64-96 deletion mutation on viral packaging)
图7为实施例5中使用2000TCID50鸭坦布苏ΔC64-96突变病毒株进行鸭胚毒力试验的结果图;Fig. 7 is the result diagram of duck embryo virulence test using 2000TCID 50 duck Tembusu ΔC64-96 mutant virus strain in Example 5;
图8为实施例6中鸭坦布苏ΔC64-96突变病毒株对5日龄雏鸭单次注射免疫的试验结果图(图8A为病毒血症滴度统计图,图8B为雏鸭死亡统计图);Fig. 8 is a graph showing the results of a single injection of duck Tembusu ΔC64-96 mutant virus strain in Example 6 to immunize 5-day-old ducklings with a single injection (Fig. 8A is a graph of viremia titer statistics, and Fig. 8B is a graph of the death statistics of ducklings) picture);
图9为实施例6中鸭坦布苏ΔC64-96突变病毒株对5日龄雏鸭单次注射免疫后攻毒试验中雏鸭体重变化图;Figure 9 is a graph showing the weight change of ducklings in the challenge test after a single injection of duck Tembusu ΔC64-96 mutant virus strain in Example 6 to 5-day-old ducklings;
图10为实施例6中鸭坦布苏ΔC64-96突变病毒株对5日龄雏鸭单次注射免疫后攻毒试验结果图(图10A为病毒血症滴度统计图,图10B为雏鸭死亡统计图);Fig. 10 is a graph showing the results of a challenge test after a single injection of duck Tembusu ΔC64-96 mutant virus strain in Example 6 to 5-day-old ducklings (Fig. 10A is a graph of viremia titers, and Fig. 10B is a graph of ducklings) death chart);
图11为实施例7中鸭坦布苏ΔC64-96突变病毒株对25日龄雏鸭免疫后第3天和第5天,雏鸭各组织的vRNA载量图;Figure 11 is the vRNA load map of each tissue of the ducklings on the 3rd and 5th days after the duck Tembusu ΔC64-96 mutant virus strain was immunized to 25-day-old ducklings in Example 7;
图12为实施例7中鸭坦布苏ΔC64-96突变病毒株对25日龄雏鸭免疫后15天内,雏鸭的死亡数量统计图;Figure 12 is a statistical graph of the number of dead ducklings within 15 days after the duck Tembusu ΔC64-96 mutant virus strain was immunized to 25-day-old ducklings in Example 7;
图13为实施例7中鸭坦布苏ΔC64-96突变病毒株对25日龄雏鸭免疫后第5天,脾组织的IFN-α,IFN-β,IL-1β和TNF-α的mRNA表达情况图;Figure 13 shows the mRNA expressions of IFN-α, IFN-β, IL-1β and TNF-α in the spleen tissue on the 5th day after immunization of 25-day-old ducklings with duck Tembusu ΔC64-96 mutant virus strain in Example 7 situation diagram;
图14为实施例7中鸭坦布苏ΔC64-96突变病毒株对25日龄雏鸭免疫后,鸭外周血的T淋巴细胞特异性增殖数据图;Figure 14 is a graph showing the specific proliferation data of T lymphocytes in the peripheral blood of ducks after the duck Tembusu ΔC64-96 mutant virus strain in Example 7 was immunized with 25-day-old ducklings;
图15为实施例7中鸭坦布苏ΔC64-96突变病毒株对25日龄雏鸭免疫14天后,鸭血清中的Th1型细胞因子IFNγ和Th2型细胞因子IL-4的表达水平数据图。15 is a graph showing the expression levels of Th1-type cytokine IFNγ and Th2-type cytokine IL-4 in duck serum 14 days after immunization of 25-day-old ducklings with duck Tembusu ΔC64-96 mutant virus strain in Example 7.
具体实施方式Detailed ways
下面结合附图和具体实施例对本发明作进一步的说明。The present invention will be further described below with reference to the accompanying drawings and specific embodiments.
质粒、细胞及实验动物:pACNR-FL-CQW1质粒载体、BHK21细胞、野生型鸭坦布苏病毒株DTMUV-CQW1、anti-TMUV的多抗均由四川农业大学动物医学院禽病防治中心提供;SPF雏鸭和SPF鸭胚购自哈尔滨兽医研究所;鸭坦布苏病毒株DTMUV-CHN-YC由华中农业大学动物医学院赠与。Plasmids, cells and experimental animals: pACNR-FL-CQW1 plasmid vector, BHK21 cells, wild-type duck Tembusu virus strain DTMUV-CQW1, and polyclonal antibodies against anti-TMUV were provided by the Center for Avian Disease Control, School of Veterinary Medicine, Sichuan Agricultural University; SPF ducklings and SPF duck embryos were purchased from Harbin Veterinary Research Institute; duck Tembusu virus strain DTMUV-CHN-YC was donated by the School of Veterinary Medicine of Huazhong Agricultural University.
主要试剂盒:ClonExpress II One Step Cloning Kit购自南京诺唯赞生物;TransIntroTM EL Transfection Reagent购自北京全式金生物;Phanta EVO HS Super-Fidelity DNAPolymerase购自南京诺唯赞生物。Main kits: ClonExpress II One Step Cloning Kit was purchased from Nanjing Novozymes; TransIntroTM EL Transfection Reagent was purchased from Beijing Quanzhijin Bio; Phanta EVO HS Super-Fidelity DNAPolymerase was purchased from Nanjing Novozymes.
实施例1Example 1
1、鸭坦布苏病毒弱毒株即鸭坦布苏ΔC64-96突变病毒株的构建1. Construction of duck tembusu virus attenuated strain, namely duck tembusu ΔC64-96 mutant virus strain
以鸭坦布苏病毒株DTMUV-CQW1株的pACNR-FL-CQW1质粒为模板,以序列SEQ IDNO.1和SEQ ID NO.2为引物,PCR扩增得到片段P1;以序列SEQ ID NO.3和SEQ ID NO.4为引物,PCR扩增得到片段P2;再以片段P1和片段P2为模板,以序列SEQ ID NO.1和SEQ ID NO.4为引物,通过融合PCR扩增得到片段P1P2,片段P1P2为基因缺失突变的核苷酸序列,片段P1P2缺失的基因序列为编码鸭坦布苏病毒的Capsid蛋白第64位-第96位氨基酸的核苷酸序列。Using the pACNR-FL-CQW1 plasmid of the duck Tembusu virus strain DTMUV-CQW1 strain as the template, and using the sequence SEQ ID NO.1 and SEQ ID NO.2 as the primers, the fragment P1 was obtained by PCR amplification; and SEQ ID NO.4 as primers, PCR amplification to obtain fragment P2; then with fragment P1 and fragment P2 as templates, with sequence SEQ ID NO.1 and SEQ ID NO.4 as primers, by fusion PCR amplification to obtain fragment P1P2 , the fragment P1P2 is the nucleotide sequence of the gene deletion mutation, and the gene sequence of the fragment P1P2 deletion is the nucleotide sequence of the 64th-96th amino acid of the Capsid protein of the duck Tembusu virus.
利用高保真酶Phanta EVO HS Super-Fidelity DNA Polymerase进行两步法融合PCR,PCR的反应体系详见表1:Two-step fusion PCR was performed using the high-fidelity enzyme Phanta EVO HS Super-Fidelity DNA Polymerase. The PCR reaction system is shown in Table 1:
PCR扩增条件为95℃预变性1min;95℃变性15s,63℃退火15s,72℃延伸15s/kb,共30个循环;最后72℃后延伸7min。每轮扩增结束后,进行凝胶电泳鉴定,并作液回收或者胶回收。PCR扩增中所使用的引物详见表2。PCR amplification conditions were pre-denaturation at 95 °C for 1 min; denaturation at 95 °C for 15 s, annealing at 63 °C for 15 s, and extension at 72 °C for 15 s/kb, a total of 30 cycles; and a final extension at 72 °C for 7 min. After each round of amplification, gel electrophoresis was performed for identification, and liquid recovery or gel recovery was performed. The primers used in PCR amplification are detailed in Table 2.
表2PCR扩增引物序列表Table 2 PCR amplification primer sequence list
2、构建重组感染性克隆质粒pACNR-FL-CQW1-ΔC64-962. Construction of recombinant infectious cloning plasmid pACNR-FL-CQW1-ΔC64-96
将pACNR-FL-CQW1质粒用限制性内切酶MluI和XhoI进行双酶切,并回收纯化,获得纯化的线性pACNR-FL-CQW1载体;使用ClonExpress II One Step Cloning Kit,按说明书将上述获得的基因缺失突变的片段P1P2与线性pACNR-FL-CQW1载体进行重组连接反应,然后转化到大肠杆菌感受态细胞,待菌落长出,挑菌进行PCR鉴定。然后,挑选PCR鉴定阳性的菌落送测序鉴定,将测序确认的质粒命名为pACNR-FL-CQW1-ΔC64-96质粒;挑选测序正确的单菌落扩大培养后保存并抽提质粒备用。The pACNR-FL-CQW1 plasmid was double digested with restriction enzymes MluI and XhoI, and recovered and purified to obtain a purified linear pACNR-FL-CQW1 vector; using the ClonExpress II One Step Cloning Kit, according to the instructions, the obtained The gene deletion mutant fragment P1P2 was recombined with the linear pACNR-FL-CQW1 vector, and then transformed into E. coli competent cells. After the colonies grew, the bacteria were picked for PCR identification. Then, the positive colonies identified by PCR were selected and sent for sequencing identification, and the plasmid confirmed by sequencing was named pACNR-FL-CQW1-ΔC64-96 plasmid; single colonies with correct sequencing were selected for expansion and culture, and the plasmid was stored and extracted for future use.
pACNR-FL-CQW1质粒图谱如附图1所示。限制性内切酶MluI和XhoI对pACNR-FL-CQW1质粒进行双酶切,切除pACNR-FL-CQW1质粒上编码Capsid蛋白的基因序列,然后将上述融合PCR获得的基因缺失突变的片段P1P2与双酶切后的线性pACNR-FL-CQW1质粒进行重组连接,获得重组质粒pACNR-FL-CQW1-ΔC64-96。pACNR-FL-CQW1-ΔC64-96质粒感染性克隆的构建示意图如附图2所示。The plasmid map of pACNR-FL-CQW1 is shown in Figure 1. The pACNR-FL-CQW1 plasmid was double digested with restriction enzymes MluI and XhoI, and the gene sequence encoding the Capsid protein on the pACNR-FL-CQW1 plasmid was excised. The digested linear pACNR-FL-CQW1 plasmid was recombined and ligated to obtain the recombinant plasmid pACNR-FL-CQW1-ΔC64-96. A schematic diagram of the construction of an infectious clone of the pACNR-FL-CQW1-ΔC64-96 plasmid is shown in FIG. 2 .
实施例2Example 2
转染及拯救鸭坦布苏ΔC64-96突变病毒株Transfection and rescue of duck Tembusu ΔC64-96 mutant virus strain
将生长状态良好的BHK21细胞接种到12孔板,培养16h,待细胞汇合度达到70~90%时,按转染试剂TransIntroTM EL Transfection Reagent说明进行以下操作。设置ΔC64-96组和WT组;ΔC64-96组每个孔转染实施例1中制备得到的pACNR-FL-CQW1-ΔC64-96质粒1.2μg,WT组每个孔转染野生型鸭坦布苏病毒株DTMUV-CQW1的质粒1.2μg。Inoculate BHK21 cells with good growth status into 12-well plates and culture for 16 hours. When the cell confluence reaches 70-90%, perform the following operations according to the instructions of TransIntroTM EL Transfection Reagent. Set ΔC64-96 group and WT group; 1.2 μg of pACNR-FL-CQW1-ΔC64-96 plasmid prepared in Example 1 was transfected in each well of ΔC64-96 group, and wild-type duck tembo was transfected in each well of WT group Plasmid 1.2 μg of Su virus strain DTMUV-CQW1.
在转染后的第5天(F0代)收获细胞爬片,用anti-TMUV的多抗进行IFA鉴定,同时收获上清感染新的BHK21细胞。在感染的第三天(F1代)收获细胞爬片进行IFA鉴定。On the 5th day after transfection (F0 generation), the cell slides were harvested and identified by IFA with anti-TMUV polyclonal antibody. At the same time, the supernatant was harvested to infect new BHK21 cells. Cell slides were harvested on the third day of infection (F1 generation) for IFA identification.
如附图3所示,ΔC64-96在F0代和F1都产生了明显的荧光信号,表明鸭坦布苏ΔC64-96突变病毒株能产生感染性的病毒粒子,且明显弱于野生型鸭坦布苏病毒株DTMUV-CQW1。As shown in Figure 3, ΔC64-96 produced obvious fluorescent signals in both the F0 generation and F1, indicating that the duck tembusu ΔC64-96 mutant virus strain can produce infectious virions, which are significantly weaker than wild-type duck tannins. Busu virus strain DTMUV-CQW1.
实施例3Example 3
验证鸭坦布苏ΔC64-96突变病毒株的致弱特性及致弱机制Validation of the weakening characteristics and weakening mechanism of duck Tembusu ΔC64-96 mutant virus strain
1、验证鸭坦布苏ΔC64-96突变病毒株的致弱特性1. Verify the weakening properties of the duck Tembusu ΔC64-96 mutant virus strain
设置ΔC64-96组和WT组。ΔC64-96组将实施例2中拯救得到的鸭坦布苏ΔC64-96突变病毒株在BHK21进行增殖并测定滴度后备用,在BHK21细胞上对其的生长曲线进行测定。WT组将野生型鸭坦布苏病毒株DTMUV-CQW1在BHK21进行增殖并测定滴度后备用,在BHK21细胞上对其的生长曲线进行测定。如附图4所示,鸭坦布苏ΔC64-96突变病毒株在BHK21细胞上的增殖与野生型鸭坦布苏病毒DTMUV-CQW1相比较表现出明显的致弱,具体表现为滴度达到峰值的时间延长,峰值的滴度降低。Set ΔC64-96 group and WT group. In the ΔC64-96 group, the duck tembusu ΔC64-96 mutant virus strain rescued in Example 2 was propagated in BHK21 and the titer was determined for use, and its growth curve was determined on BHK21 cells. In the WT group, the wild-type duck Tembusu virus strain DTMUV-CQW1 was propagated in BHK21 and the titer was determined for use, and its growth curve was determined on BHK21 cells. As shown in Figure 4, the proliferation of duck tembusu ΔC64-96 mutant virus strain on BHK21 cells was significantly weakened compared with that of wild-type duck tembusu virus DTMUV-CQW1, and the specific manifestation was that the titer reached a peak. The time was prolonged, and the peak titer decreased.
将实施例2中拯救得到的鸭坦布苏ΔC64-96突变病毒株在BHK21细胞上连续传代10次,对鸭坦布苏ΔC64-96突变病毒株的F1代和F10代进行噬斑试验,分别记为ΔC64-96-F1和ΔC64-96-F10,以野生型鸭坦布苏病毒DTMUV-CQW1做对照,记为WT组。如附图5所示,噬斑试验结果表明,ΔC64-96-F1和ΔC64-96-F10仅形成针尖大小的噬斑;且传代10次之后,ΔC64-96-F10形成的噬斑与F1代相比,没有明显的大小差异,均远小于WT组的噬斑。噬斑试验的结果表明第10代鸭坦布苏ΔC64-96突变病毒株的增殖能力与第一代相比几乎没有变化,且均弱于野生型病毒株。The duck tembusu ΔC64-96 mutant virus strain rescued in Example 2 was serially passaged 10 times on BHK21 cells, and plaque assays were performed on the F1 and F10 generations of the duck tembusu ΔC64-96 mutant virus strain, respectively. Denoted as ΔC64-96-F1 and ΔC64-96-F10, with wild-type duck Tembusu virus DTMUV-CQW1 as the control, denoted as WT group. As shown in Figure 5, the plaque test results showed that ΔC64-96-F1 and ΔC64-96-F10 only formed plaques the size of pinpoints; and after 10 passages, the plaques formed by ΔC64-96-F10 were similar to those of F1 passage. In contrast, there was no significant difference in size, and the plaques were much smaller than those in the WT group. The results of the plaque assay showed that the proliferation ability of the 10th generation duck Tembusu ΔC64-96 mutant strain had little change compared with the first generation, and was weaker than that of the wild-type strain.
2、验证鸭坦布苏ΔC64-96突变病毒株的致弱机制2. Verify the weakening mechanism of the duck Tembusu ΔC64-96 mutant virus strain
由于Capsid蛋白在鸭坦布苏病毒的组装过程中发挥了关键的作用,与病毒的基因组RNA共同形成核衣壳,且其α4螺旋结构被认为是与病毒基因组RNA结合的关键稳点,而鸭坦布苏ΔC64-96突变病毒株恰好删除了这一关键区域,因此本实施例通过包装实验来验证鸭坦布苏ΔC64-96突变病毒株是否在病毒的组装过程存在缺陷。如附图6A所示,将WT型(或ΔC64-96)的C-prM表达质粒与缺失了C蛋白且带有Nluc荧光素酶基因的亚基因组复制子质粒共转染BHK21细胞,通过反式互补的方式产生单轮感染性病毒粒子,记为WT组(或ΔC64-96组)。在转染后第三天收获上清感染新的BHK21细胞,并在感染后24小时测定荧光值。结果表明,与WT组相比,ΔC64-96组打包复制子RNA的能力显著降低(附图6B)。Since the Capsid protein plays a key role in the assembly process of duck Tembusu virus, it forms a nucleocapsid together with the viral genomic RNA, and its α4 helix structure is considered to be a key stable point for binding to the viral genomic RNA, while duck The Tempusu ΔC64-96 mutant virus strain just deleted this key region, so this example uses packaging experiments to verify whether the duck Tempusu ΔC64-96 mutant virus strain has defects in the virus assembly process. As shown in Fig. 6A, the WT type (or ΔC64-96) C-prM expression plasmid was co-transfected into BHK21 cells with a subgenomic replicon plasmid lacking C protein and carrying the Nluc luciferase gene. A single round of infectious virions was generated in a complementary manner, denoted as the WT group (or ΔC64-96 group). The supernatant was harvested on the third day after transfection to infect new BHK21 cells, and the fluorescence value was measured 24 hours after infection. The results showed that the ability of the ΔC64-96 group to package replicon RNA was significantly reduced compared with the WT group (Fig. 6B).
综上,鸭坦布苏ΔC64-96突变病毒株的删除突变造成了病毒粒子在组装过程中的缺陷,这是鸭坦布苏ΔC64-96突变病毒株在体外致弱的主要原因。因此,病毒粒子装配的缺陷是鸭坦布苏ΔC64-96突变病毒株致弱的分子基础。In conclusion, the deletion mutation of the duck tembusu ΔC64-96 mutant virus strain caused defects in the assembly process of the virion, which was the main reason for the weakening of the duck tembusu ΔC64-96 mutant virus strain in vitro. Therefore, defects in virion assembly are the molecular basis for the weakening of the duck Tembusu ΔC64-96 mutant strain.
实施例4Example 4
验证鸭坦布苏ΔC64-96突变病毒株遗传稳定性Validation of the genetic stability of the duck Tembusu ΔC64-96 mutant virus strain
将实施例2中拯救得到的鸭坦布苏ΔC64-96突变病毒株在BHK21细胞上连续传代10次,然后进行病毒全基因组测序;测序结果显示,传代10次以后,鸭坦布苏ΔC64-96突变病毒的基因缺失突变仍然稳定存在于突变病毒的基因组,表明鸭坦布苏ΔC64-96突变病毒在C蛋白第64位-第96位的删除突变具有遗传稳定性。同时在鸭坦布苏ΔC64-96突变病毒的基因组上还出现了其他的适应性突变,如表3所示。The duck Tembusu ΔC64-96 mutant virus strain rescued in Example 2 was serially passaged on BHK21 cells for 10 times, and then the virus whole genome was sequenced; the sequencing results showed that after 10 passages, duck Tembusu ΔC64-96 The gene deletion mutation of the mutant virus still exists stably in the genome of the mutant virus, indicating that the deletion mutation at the 64th-96th position of the C protein of the duck Tembusu ΔC64-96 mutant virus has genetic stability. At the same time, other adaptive mutations appeared in the genome of duck Tembusu ΔC64-96 mutant virus, as shown in Table 3.
表3鸭坦布苏ΔC64-96突变病毒的传代稳定性Table 3 Passaging stability of duck Tembusu ΔC64-96 mutant virus
实施例5Example 5
鸭坦布苏ΔC64-96突变病毒株对鸭胚毒力影响试验Experiment on the effect of duck Tembusu ΔC64-96 mutant virus strain on duck embryo virulence
设置ΔC64-96-F1组、ΔC64-96-F10组、CQW1-WT组和Mock组,每组各10只鸭胚。将实施例2获得的鸭坦布苏ΔC64-96突变病毒株连续培养10代后,获得鸭坦布苏ΔC64-96突变病毒株F1代、鸭坦布苏ΔC64-96突变病毒株F10代。ΔC64-96-F1组、ΔC64-96-F10组、CQW1-WT组的鸭胚分别注射2000TCID50的鸭坦布苏ΔC64-96突变病毒株F1代、鸭坦布苏ΔC64-96突变病毒株F10代、野生型鸭坦布苏病毒株DTMUV-CQW1病毒。Mock组注射等剂量的DMEM。攻毒后连续观察7日,每天记录鸭胚死亡情况。试验结果如附图7所示,CQW1-WT组的鸭胚全部在4天死亡,相比之下,有70%的鸭胚死于ΔC64-96-F1的感染,且ΔC64-96-F10的鸭胚毒力进一步降低,只有10%的鸭胚死亡。The ΔC64-96-F1 group, the ΔC64-96-F10 group, the CQW1-WT group and the Mock group were set, with 10 duck embryos in each group. After the duck tembusu ΔC64-96 mutant virus strain obtained in Example 2 was continuously cultured for 10 generations, the F1 generation of the duck tembusu ΔC64-96 mutant virus strain and the F10 generation of the duck tembusu ΔC64-96 mutant virus strain were obtained. Duck embryos of ΔC64-96-F1 group, ΔC64-96-F10 group and CQW1-WT group were injected with 2000 TCID 50 of duck tembusu ΔC64-96 mutant virus strain F1 generation and duck tembusu ΔC64-96 mutant virus strain F10, respectively Generation, wild-type duck Tembusu virus strain DTMUV-CQW1 virus. The Mock group was injected with the same dose of DMEM. After the challenge, the animals were observed for 7 consecutive days, and the death of duck embryos was recorded every day. The test results are shown in Figure 7. All duck embryos in the CQW1-WT group died within 4 days. In contrast, 70% of the duck embryos died of ΔC64-96-F1 infection, and ΔC64-96-F10 embryos died. The virulence of duck embryos was further reduced, and only 10% of duck embryos died.
上述试验分析表明,鸭坦布苏ΔC64-96突变病毒株的突变显著降低了鸭坦布苏病毒的鸭胚毒力,且适应细胞后的鸭坦布苏ΔC64-96突变病毒株F10在F1的基础上,毒力进一步降低。The above experimental analysis showed that the mutation of the duck tembusu ΔC64-96 mutant virus strain significantly reduced the duck embryo virulence of duck tembusu virus, and the duck tembusu ΔC64-96 mutant virus strain F10 after adaptation to cells was in the F1 On the basis, the virulence is further reduced.
实施例6Example 6
鸭坦布苏ΔC64-96突变病毒株对5日龄雏鸭免疫后的免疫保护Immune protection of duck Tembusu ΔC64-96 mutant virus strain after immunization of 5-day-old ducklings
将5日龄雏鸭随机分成3组,分别记为CQW1组、ΔC64-96组和DMEM组,通过肌肉注射,给予CQW1组接种200μL(105TCID50)的野生型鸭坦布苏病毒DTMUV-CQW1;ΔC64-96组接种200μL(105TCID50)鸭坦布苏ΔC64-96突变病毒进行免疫;DMEM组注射等剂量的DMEM。在免疫后第1-14天,检测3组雏鸭体重变化,临床症状及死亡情况,并在第3天测定病毒血症的水平;在免疫后第14天,对3个组的所有幸存雏鸭进行攻毒,即通过肌肉接种200μL(2×106TCID50)的鸭坦布苏病毒株DTMUV-CHN-YC,并在攻毒后14天内监测各组雏鸭的体重变化、临床症状以及死亡情况,在攻毒后的第3天测定病毒血症的水平。The 5-day-old ducklings were randomly divided into 3 groups, designated as CQW1 group, ΔC64-96 group and DMEM group, respectively. The CQW1 group was inoculated with 200 μL (10 5 TCID 50 ) of wild-type duck Tembusu virus DTMUV- CQW1; ΔC64-96 group was inoculated with 200 μL (10 5 TCID 50 ) of duck Tembusu ΔC64-96 mutant virus for immunization; DMEM group was injected with the same dose of DMEM. On the 1st to 14th day after immunization, the weight changes, clinical symptoms and death of the three groups of ducklings were detected, and the level of viremia was determined on the 3rd day; on the 14th day after immunization, all surviving chicks in the three groups were tested Ducks were challenged by intramuscular inoculation of 200 μL (2×10 6 TCID 50 ) of duck Tembusu virus strain DTMUV-CHN-YC, and the weight changes, clinical symptoms and In case of death, the level of viremia was determined on the 3rd day post-challenge.
在免疫后第3天,我们对3组雏鸭的病毒血症进行了测定。如图8A所示,CQW1组产生了高水平的病毒血症,病毒滴度达到了104TCID50/100μL,ΔC64-96组和DMEM组均没有检测到病毒血症。从免疫后第3天开始,CQW1组的雏鸭出现精神沉郁、行动迟缓、站立不稳甚至后肢瘫痪等临床症状;并从第5天开始出现死亡,到第7天,有60%的雏鸭死于野生型鸭坦布苏病毒DTMUV-CQW1的感染(图8B)。而ΔC64-96和DMEM组未出现任何明显临床症状和死亡情况(图8B)。如附图9所示,在免疫后第4天开始,CQW1组的体重增长水平明显低于DMEM组,而ΔC64-96组与DMEM组相比没有明显的差异。这些数据表明了鸭坦布苏ΔC64-96突变病毒对雏鸭的毒力显著降低。On the 3rd day after immunization, we measured the viremia of 3 groups of ducklings. As shown in Fig. 8A, the CQW1 group developed a high level of viremia, and the virus titer reached 10 4 TCID 50/100 μL, and neither the ΔC64-96 group nor the DMEM group detected viremia. From the 3rd day after immunization, the ducklings in the CQW1 group developed clinical symptoms such as depression, slow movement, unsteady standing and even hindlimb paralysis; and died from the 5th day, and by the 7th day, 60% of the ducklings Died from infection with wild-type duck Tembusu virus DTMUV-CQW1 (FIG. 8B). However, the ΔC64-96 and DMEM groups did not experience any obvious clinical symptoms and death (Fig. 8B). As shown in Fig. 9, starting from the 4th day after immunization, the level of body weight gain in the CQW1 group was significantly lower than that in the DMEM group, while the ΔC64-96 group had no significant difference compared with the DMEM group. These data indicate that the virulence of duck Tembusu ΔC64-96 mutant virus to ducklings is significantly reduced.
如附图9所示,在攻毒后的第二天,DMEM的体重显著低于ΔC64-96,且开始出现精神沉郁、行动迟缓、站立不稳甚至后肢瘫痪等临床症状。检测攻毒后第3天的病毒血症情况发现,除DMEM组产生了明显的病毒血症外,ΔC64-96租和CQW1组都未产生病毒血症(图10A)。如附图10B所示,在攻毒后的第5天和第7天,DMEM组分别有1只雏鸭死亡;而ΔC64-96组和CQW1组未出现任何死亡情况。As shown in Figure 9, on the second day after challenge, the body weight of DMEM was significantly lower than that of ΔC64-96, and clinical symptoms such as depression, slow movement, unsteady standing and even hind limb paralysis began to appear. Viremia was detected on
以上数据表明,单次肌肉注射免疫鸭坦布苏ΔC64-96突变病毒株,即能为雏鸭提供有效的免疫保护效果。The above data show that a single intramuscular injection of immunized duck Tembusu ΔC64-96 mutant virus strain can provide effective immune protection for ducklings.
实施例7Example 7
鸭坦布苏ΔC64-96突变病毒株在25日龄雏鸭体内诱导免疫反应机制Mechanism of immune response induced by duck Tembusu ΔC64-96 mutant virus strain in 25-day-old ducklings
为了进一步验证鸭坦布苏ΔC64-96突变病毒株为雏鸭提供免疫保护,在雏鸭体内诱导免疫反应的机制,本实施例将25日龄雏鸭随机分为3组,分别为CQW1组、DMEM组、ΔC64-96组,每组11只。CQW1组通过肌肉注射200μL的野生型鸭坦布苏DTMUV-CQW1病毒,ΔC64-96组通过肌肉注射200μL的鸭坦布苏ΔC64-96突变病毒,DMEM组通过肌肉注射等剂量的DMEM。在免疫后的第3天、第5天,每组分别随机剖杀3只雏鸭,采取雏鸭的心、肝、脾、肺、肾、脑和胸腺组织样品。每组剩余的5只连续观察14天,记录死亡情况。在免疫后的第14天,测定其细胞免疫情况。In order to further verify the mechanism by which the duck Tembusu ΔC64-96 mutant virus strain provides immune protection for ducklings and induces an immune response in the ducklings, in this example, the 25-day-old ducklings were randomly divided into three groups, namely the CQW1 group, DMEM group, ΔC64-96 group, 11 in each group. The CQW1 group received 200 μL of wild-type duck tembusu DTMUV-CQW1 virus intramuscularly, the ΔC64-96 group received 200 μL of duck tembusu ΔC64-96 mutant virus intramuscularly, and the DMEM group received the same dose of DMEM by intramuscular injection. On the 3rd and 5th days after immunization, 3 ducklings in each group were sacrificed at random, and the heart, liver, spleen, lung, kidney, brain and thymus tissue samples of the ducklings were collected. The remaining 5 animals in each group were observed for 14 consecutive days, and the death was recorded. On the 14th day after immunization, the cellular immunity was measured.
如图11所示,在免疫后的第三天,CQW1组在各个脏器均能检测到高滴度的vRNA的载量,且在感染后的第5天进一步上升。相比之下,ΔC64-96组的各个脏器的vRNA载量都始终保持在一个最低的水平。如图12所示,在感染后第5天,CQW1组有一只雏鸭出现明显临床症状并死亡;而ΔC64-96组中,没有雏鸭出现临床症状和死亡。As shown in Fig. 11 , on the third day after immunization, the load of vRNA with high titer in each organ of the CQW1 group could be detected, and it further increased on the fifth day after infection. In contrast, the vRNA load of each organ in the ΔC64-96 group was always kept at the lowest level. As shown in Figure 12, on the 5th day after infection, one duckling in the CQW1 group developed obvious clinical symptoms and died; while in the ΔC64-96 group, no duckling developed clinical symptoms and died.
为了分析鸭坦布苏ΔC64-96突变病毒的感染对先天免疫的激活情况,本实施例用RT-qPCR进一步检测了感染后第5天,脾组织的IFN-α,IFN-β,IL-1β和TNF-α的mRNA表达情况。如附图13所示与DMEM组相比,CQW1组和ΔC64-96组都能激活IFN-α,IFN-β,IL-1β和TNF-α的上调。In order to analyze the activation of innate immunity caused by the infection of duck tembusu ΔC64-96 mutant virus, RT-qPCR was used to further detect IFN-α, IFN-β, IL-1β in spleen tissue on the 5th day after infection and TNF-α mRNA expression. As shown in Figure 13, compared with the DMEM group, both the CQW1 group and the ΔC64-96 group could activate the up-regulation of IFN-α, IFN-β, IL-1β and TNF-α.
为了验证鸭坦布苏ΔC64-96突变病毒的感染能否激活鸭体的细胞免疫,本实施例分离了鸭外周血的T淋巴细胞进行了T细胞特异性增殖试验。如图14所示,相比于DMEM组,CQW1组的刺激系数达到了6.2,而ΔC64-96组为4.8。本实施例进一步用ELISA测定了免疫后第14天后,鸭血清中的Th1型细胞因子IFNγ和Th2型细胞因子IL-4的表达水平。如图15所示,相对DMEM组,ΔC64-96的Th1型细胞因子IFNγ和Th2型细胞因子IL-4的表达水平显著上调。以上数据均表明鸭坦布苏ΔC64-96突变病毒的感染能有效激活细胞免疫。In order to verify whether the infection of duck Tembusu ΔC64-96 mutant virus can activate the cellular immunity of ducks, in this example, T lymphocytes from the peripheral blood of ducks were isolated for T cell specific proliferation test. As shown in Figure 14, compared with the DMEM group, the stimulation coefficient of the CQW1 group reached 6.2, while that of the ΔC64-96 group was 4.8. In this example, the expression levels of Th1-type cytokine IFNγ and Th2-type cytokine IL-4 in duck serum on the 14th day after immunization were further measured by ELISA. As shown in FIG. 15 , the expression levels of Th1-type cytokine IFNγ and Th2-type cytokine IL-4 in ΔC64-96 were significantly up-regulated relative to the DMEM group. All the above data indicated that the infection of duck Tembusu ΔC64-96 mutant virus could effectively activate cellular immunity.
综上所述,本发明中鸭坦布苏ΔC64-96突变病毒株通过基因缺失突变获得,删除了编码鸭坦布苏病毒Capsid蛋白第64位-第96位氨基酸的核苷酸序列,使Capsid蛋白第64位-第96位氨基酸缺失。本发明实施例3中验证了该病毒株的致弱机制,该病毒株在病毒粒子的组装过程中存在缺陷,也就是说其删除了编码鸭坦布苏病毒Capsid蛋白第64位-第96位氨基酸的核苷酸序列后,明显降低了打包复制子RNA的能力,从而使突变病毒致弱,显著降低病毒在鸭胚和雏鸭上的毒力。实施例4证明本发明中的鸭坦布苏ΔC64-96突变病毒的基因突变具有遗传稳定性。实施例6和实施例7表明,利用鸭坦布苏ΔC64-96突变病毒对雏鸭进行单次免疫就能显著激活受感染雏鸭的IFN-α,IFN-β,IL-1β、TNF-α、Th1型细胞因子IFNγ和Th2型细胞因子IL-4的表达水平上调,为雏鸭提供有效的免疫保护。To sum up, the duck Tembusu ΔC64-96 mutant virus strain in the present invention is obtained by gene deletion mutation, and the nucleotide sequence encoding the 64th-96th amino acids of the Capsid protein of duck Tembusu virus is deleted, so that the Capsid The 64th-96th amino acid of the protein is deleted. The weakening mechanism of the virus strain was verified in Example 3 of the present invention. The virus strain has defects in the assembly process of the virus particles, that is to say, it deletes the 64th to 96th positions of the Capsid protein encoding duck Tembusu virus. After the nucleotide sequence of amino acids, the ability to package the replicon RNA was significantly reduced, thereby weakening the mutant virus and significantly reducing the virulence of the virus on duck embryos and ducklings. Example 4 proves that the gene mutation of the duck Tembusu ΔC64-96 mutant virus in the present invention has genetic stability. Example 6 and Example 7 show that a single immunization of ducklings with duck Tembusu ΔC64-96 mutant virus can significantly activate IFN-α, IFN-β, IL-1β, TNF-α in infected ducklings , Th1-type cytokine IFNγ and Th2-type cytokine IL-4 expression levels were up-regulated, providing effective immune protection for ducklings.
以上分析说明鸭坦布苏ΔC64-96突变病毒株的致弱效果明显,其致弱机制被清楚解析,且具有明显的遗传稳定性,因此能有效提高其使用的安全性。使用该病毒株免疫雏鸭,能有效激活被免疫雏鸭的免疫系统,使多个免疫相关细胞因子的表达水平显著上调,为雏鸭提供高效的免疫保护。因此,本发明中的鸭坦布苏ΔC64-96突变病毒株是一株安全且高效的致弱活疫苗候选病毒株,将其制备成鸭坦布苏病毒致弱活疫苗可广泛应用于鸭坦布苏相关疾病的预防。The above analysis shows that duck tembusu ΔC64-96 mutant virus strain has obvious weakening effect, its weakening mechanism has been clearly analyzed, and it has obvious genetic stability, so it can effectively improve the safety of its use. Using this virus strain to immunize ducklings can effectively activate the immune system of the immunized ducklings, significantly up-regulate the expression levels of multiple immune-related cytokines, and provide efficient immune protection for the ducklings. Therefore, the duck tembusu ΔC64-96 mutant virus strain in the present invention is a safe and efficient attenuated live vaccine candidate virus strain, and it can be widely used in duck tambusu virus by preparing it into a duck tembusu virus attenuated live vaccine Prevention of Busu-related diseases.
本发明的说明书和附图被认为是说明性的而非限制性的,在本发明基础上,本领域技术人员根据所公开的技术内容,不需要创造性的劳动就可以对其中一些技术特征做出一些替换和变形,均在本发明的保护范围内。The description and drawings of the present invention are considered to be illustrative rather than restrictive. On the basis of the present invention, those skilled in the art can make some technical features without creative work according to the disclosed technical content. Some replacements and modifications are within the protection scope of the present invention.
序列表 sequence listing
<110> 四川农业大学<110> Sichuan Agricultural University
<120> 一种鸭坦布苏病毒致弱活疫苗候选株及其制备方法和应用<120> A candidate strain of duck Tembusu virus attenuated live vaccine and its preparation method and application
<141> 2021-05-17<141> 2021-05-17
<160> 8<160> 8
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 45<211> 45
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 1<400> 1
gtatcataca catacgacgc gttggagttc cgcgttacat aactt 45gtatcataca catacgacgc gttggagttc cgcgttacat aactt 45
<210> 2<210> 2
<211> 20<211> 20
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 2<400> 2
ggttggcctc agggctgtaa 20ggttggcctc agggctgtaa 20
<210> 3<210> 3
<211> 38<211> 38
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 3<400> 3
acagccctga ggccaaccaa taagcggaag gcgaaacg 38acagccctga ggccaaccaa taagcggaag gcgaaacg 38
<210> 4<210> 4
<211> 39<211> 39
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 4<400> 4
tgtaaccttg atacttacct cgagcctgct gactgatcg 39tgtaaccttg atacttacct cgagcctgct gactgatcg 39
<210> 5<210> 5
<211> 839<211> 839
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 5<400> 5
gtatcataca catacgacgc gttggagttc cgcgttacat aacttacggt aaatggcccg 60gtatcataca catacgacgc gttggagttc cgcgttacat aacttacggt aaatggcccg 60
cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata 120cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata 120
gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc 180gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc 180
cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga cgtcaatgac 240cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga cgtcaatgac 240
ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt tcctacttgg 300ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt tcctacttgg 300
cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg gcagtacatc 360cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg gcagtacatc 360
aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc 420aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc 420
aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taacaactcc 480aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taacaactcc 480
gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct 540gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct 540
ggtttagtga accgtagaag ttcatctgtg tgaacttatt ccaaacagtt ttttgggata 600ggtttagtga accgtagaag ttcatctgtg tgaacttatt ccaaacagtt ttttgggata 600
gtgcgtgtga acgtaaacac agtttgaacg ttttttggat agagacaact atgtctaaca 660gtgcgtgtga acgtaaacac agtttgaacg ttttttggat agagacaact atgtctaaca 660
aaaaaccagg aagacccggc tcaggccggg ttgtcaatat gctaaagcgc ggaacgtccc 720aaaaaccagg aagacccggc tcaggccggg ttgtcaatat gctaaagcgc ggaacgtccc 720
gcggaaatcc gctagcgcgg ataaagagga cgattgatgg ggtcctgaga ggagcaggac 780gcggaaatcc gctagcgcgg ataaagagga cgattgatgg ggtcctgaga ggagcaggac 780
ccataaggtt tgtgctggct ctactgactt tcttcaagtt tacagccctg aggccaacc 839ccataaggtt tgtgctggct ctactgactt tcttcaagtt tacagccctg aggccaacc 839
<210> 6<210> 6
<211> 2306<211> 2306
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 6<400> 6
ttacagccct gaggccaacc aataagcgga aggcgaaacg tcgggggggg agttgctctt 60ttacagccct gaggccaacc aataagcgga aggcgaaacg tcgggggggg agttgctctt 60
gggtcatcat gttactcccg atagttgctg ggctgaaact tggaaattat aatggtagag 120gggtcatcat gttactcccg atagttgctg ggctgaaact tggaaattat aatggtagag 120
ttttggccac tttaaacaag actgatgtgt cagacttgct agtcattcca acaacggctg 180ttttggccac tttaaacaag actgatgtgt cagacttgct agtcattcca acaacggctg 180
gcagcaatgg atgcgtcgtg cgagctctag atgtgggact gatgtgtcag gatgacataa 240gcagcaatgg atgcgtcgtg cgagctctag atgtgggact gatgtgtcag gatgacataa 240
cgtacctgtg cccaaagttg gagtacggct atgaacctga agacatagac tgctggtgca 300cgtacctgtg cccaaagttg gagtacggct atgaacctga agacatagac tgctggtgca 300
atgagactga gatatacatt cattatggga gatgtacccc ttcacggcat ggacggaggt 360atgagactga gatatacatt cattatggga gatgtacccc ttcacggcat ggacggaggt 360
ctaggaggtc ggtgaacgtg catcaccatg gagagagtct acttgaggcc aagaacacgc 420ctaggaggtc ggtgaacgtg catcaccatg gagagagtct acttgaggcc aagaacacgc 420
cgtggatgga ttcgaccaaa gccactaaat atctcacaaa ggttgagaac tgggcgttga 480cgtggatgga ttcgaccaaa gccactaaat atctcacaaa ggttgagaac tgggcgttga 480
gaaatcctgg gtacgccctt gctgccatct tcataggctg gaacttggga acgacgagaa 540gaaatcctgg gtacgccctt gctgccatct tcataggctg gaacttggga acgacgagaa 540
gccagaagat aattttcaca attatgttaa tgttaattgc cccagcgtac agcttcagct 600gccagaagat aattttcaca attatgttaa tgttaattgc cccagcgtac agcttcagct 600
gtctggggat gcagaaccga gactttgttg agggagtgaa tggtgttgag tggatcgatg 660gtctggggat gcagaaccga gactttgttg agggagtgaa tggtgttgag tggatcgatg 660
tcgttctgga aggaggctca tgcgtaacta ttacggcaaa agacaggccg accatagacg 720tcgttctgga aggaggctca tgcgtaacta ttacggcaaa agacaggccg accatagacg 720
tcaagatgat gaacatggag gctacggaat tagcggttgt gagatcttac tgctatgagc 780tcaagatgat gaacatggag gctacggaat tagcggttgt gagatcttac tgctatgagc 780
cgaaagtgtc ggacgtgacg acagaatcca gatgcccaac catgggagag gctcataatc 840cgaaagtgtc ggacgtgacg acagaatcca gatgcccaac catgggagg gctcataatc 840
ccaaggcaac ttatgctgaa tacatatgca aaaaagattt tgtggacagg ggttggggca 900ccaaggcaac ttatgctgaa tacatatgca aaaaagattt tgtggacagg ggttggggca 900
atggctgtgg cttgtttgga aaggggagca tccagacatg tgccaagttt gactgcacaa 960atggctgtgg cttgtttgga aaggggagca tccagacatg tgccaagttt gactgcacaa 960
agaaagcaga aggcaggatc gtgcagaagg aaaacgtcca gtttgaagtt gcagttttta 1020agaaagcaga aggcaggatc gtgcagaagg aaaacgtcca gtttgaagtt gcagttttta 1020
tacatggttc cacggaagcg agcacctacc acaattattc agcccagcag tcgctgaaac 1080tacatggttc cacggaagcg agcacctacc acaattattc agcccagcag tcgctgaaac 1080
atgccgctag attcgtgata acgcccaaaa gtcccgtcta cactgctgag atggaggatt 1140atgccgctag attcgtgata acgcccaaaa gtcccgtcta cactgctgag atggaggatt 1140
atggtaccgt cacactcgaa tgcgaacccc gatctggggt tgacatgggg caattctacg 1200atggtaccgt cacactcgaa tgcgaacccc gatctggggt tgacatgggg caattctacg 1200
tcttcaccat gaatacaaag agctggcttg ttaacagaga ctggtttcat gacctcaact 1260tcttcaccat gaatacaaag agctggcttg ttaacagaga ctggtttcat gacctcaact 1260
taccatggac agggtcatca gcggggacgt ggcaaaacaa agagtcattg atagaatttg 1320taccatggac agggtcatca gcggggacgt ggcaaaacaa agagtcattg atagaatttg 1320
aggaggctca tgccaccaaa caatcagtgg tggctttggc atcacaagaa ggagccctcc 1380aggaggctca tgccaccaaa caatcagtgg tggctttggc atcacaagaa ggagccctcc 1380
atgcagcatt ggcgggagct attccagtga agtactctgg aaacaaattg gaaatgacct 1440atgcagcatt ggcgggagct attccagtga agtactctgg aaacaaattg gaaatgacct 1440
caggtcatct taaatgcagg gtcaaaatgc agggtttgaa gctgaaagga atgacctacc 1500caggtcatct taaatgcagg gtcaaaatgc agggtttgaa gctgaaagga atgacctacc 1500
cgatgtgtag caatacattt tccctagtga agaatcctac cgacactggg catggcactg 1560cgatgtgtag caatacattt tccctagtga agaatcctac cgacactggg catggcactg 1560
tcgtggtgga attgtcttat gcaggtaccg atgggccctg tagagttccc atatccatgt 1620tcgtggtgga attgtcttat gcaggtaccg atgggccctg tagagttccc atatccatgt 1620
cggcagattt gaatgacatg acaccagttg gacgcttgat aacagtcaac ccatacgtgt 1680cggcagattt gaatgacatg acaccagttg gacgcttgat aacagtcaac ccatacgtgt 1680
cgacttcctc cacgggtgcc aagataatgg tggaagtgga acctccattc ggggattcat 1740cgacttcctc cacgggtgcc aagataatgg tggaagtgga acctccattc ggggattcat 1740
ttattttagt aggaagtgga aaaggacaga ttaggtacca gtggcataga agtgggagta 1800ttattttagt aggaagtgga aaaggacaga ttaggtacca gtggcataga agtgggagta 1800
caattggaaa agctttcacg tcaacactca aaggagcaca aaggatggtt gctttgggtg 1860caattggaaa agctttcacg tcaacactca aaggagcaca aaggatggtt gctttgggtg 1860
acactgcatg ggattttggt tcagttgggg gtgtactcac ttccattggg aaaggcattc 1920acactgcatg ggattttggt tcagttgggg gtgtactcac ttccattggg aaaggcattc 1920
atcaagtctt cggctcagca tttaaaagct tatttggagg aatgtcatgg attactcaag 1980atcaagtctt cggctcagca tttaaaagct tatttggagg aatgtcatgg attactcaag 1980
gcatgttagg ggcactgcta ttgtggatgg gcctgaatgc aagggacaga tccatttcta 2040gcatgttagg ggcactgcta ttgtggatgg gcctgaatgc aagggacaga tccatttcta 2040
tgacctttct agtcgtagga ggaattttag tcttcttggc agtaaatgtc aatgccgaca 2100tgacctttct agtcgtagga ggaattttag tcttcttggc agtaaatgtc aatgccgaca 2100
cggggtgctc aatcgacttg gctaggaaag aattaaaatg tggacaaggc atgtttgtct 2160cggggtgctc aatcgacttg gctaggaaag aattaaaatg tggacaaggc atgtttgtct 2160
tcaacgatgt tgaggcctgg aaggataatt acaagtacta tccatccaca ccaaggagac 2220tcaacgatgt tgaggcctgg aaggataatt acaagtacta tccatccaca ccaaggagac 2220
ttgccaaagt cgtggcaaaa gctcatgagg ctggaatttg tggcatacga tcagtcagca 2280ttgccaaagt cgtggcaaaa gctcatgagg ctggaatttg tggcatacga tcagtcagca 2280
ggctcgaggt aagtatcaag gttaca 2306ggctcgaggt aagtatcaag gttaca 2306
<210> 7<210> 7
<211> 3125<211> 3125
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 7<400> 7
gtatcataca catacgacgc gttggagttc cgcgttacat aacttacggt aaatggcccg 60gtatcataca catacgacgc gttggagttc cgcgttacat aacttacggt aaatggcccg 60
cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata 120cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata 120
gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc 180gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc 180
cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga cgtcaatgac 240cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga cgtcaatgac 240
ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt tcctacttgg 300ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt tcctacttgg 300
cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg gcagtacatc 360cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg gcagtacatc 360
aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc 420aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc 420
aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taacaactcc 480aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taacaactcc 480
gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct 540gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct 540
ggtttagtga accgtagaag ttcatctgtg tgaacttatt ccaaacagtt ttttgggata 600ggtttagtga accgtagaag ttcatctgtg tgaacttatt ccaaacagtt ttttgggata 600
gtgcgtgtga acgtaaacac agtttgaacg ttttttggat agagacaact atgtctaaca 660gtgcgtgtga acgtaaacac agtttgaacg ttttttggat agagacaact atgtctaaca 660
aaaaaccagg aagacccggc tcaggccggg ttgtcaatat gctaaagcgc ggaacgtccc 720aaaaaccagg aagacccggc tcaggccggg ttgtcaatat gctaaagcgc ggaacgtccc 720
gcggaaatcc gctagcgcgg ataaagagga cgattgatgg ggtcctgaga ggagcaggac 780gcggaaatcc gctagcgcgg ataaagagga cgattgatgg ggtcctgaga ggagcaggac 780
ccataaggtt tgtgctggct ctactgactt tcttcaagtt tacagccctg aggccaacca 840ccataaggtt tgtgctggct ctactgactt tcttcaagtt tacagccctg aggccaacca 840
ataagcggaa ggcgaaacgt cgggggggga gttgctcttg ggtcatcatg ttactcccga 900ataagcggaa ggcgaaacgt cgggggggga gttgctcttg ggtcatcatg ttactcccga 900
tagttgctgg gctgaaactt ggaaattata atggtagagt tttggccact ttaaacaaga 960tagttgctgg gctgaaactt ggaaattata atggtagagt tttggccact ttaaacaaga 960
ctgatgtgtc agacttgcta gtcattccaa caacggctgg cagcaatgga tgcgtcgtgc 1020ctgatgtgtc agacttgcta gtcattccaa caacggctgg cagcaatgga tgcgtcgtgc 1020
gagctctaga tgtgggactg atgtgtcagg atgacataac gtacctgtgc ccaaagttgg 1080gagctctaga tgtgggactg atgtgtcagg atgacataac gtacctgtgc ccaaagttgg 1080
agtacggcta tgaacctgaa gacatagact gctggtgcaa tgagactgag atatacattc 1140agtacggcta tgaacctgaa gacatagact gctggtgcaa tgagactgag atatacattc 1140
attatgggag atgtacccct tcacggcatg gacggaggtc taggaggtcg gtgaacgtgc 1200attatgggag atgtacccct tcacggcatg gacggaggtc taggaggtcg gtgaacgtgc 1200
atcaccatgg agagagtcta cttgaggcca agaacacgcc gtggatggat tcgaccaaag 1260atcaccatgg agagagtcta cttgaggcca agaacacgcc gtggatggat tcgaccaaag 1260
ccactaaata tctcacaaag gttgagaact gggcgttgag aaatcctggg tacgcccttg 1320ccactaaata tctcacaaag gttgagaact gggcgttgag aaatcctggg tacgcccttg 1320
ctgccatctt cataggctgg aacttgggaa cgacgagaag ccagaagata attttcacaa 1380ctgccatctt cataggctgg aacttgggaa cgacgagaag ccagaagata attttcacaa 1380
ttatgttaat gttaattgcc ccagcgtaca gcttcagctg tctggggatg cagaaccgag 1440ttatgttaat gttaattgcc ccagcgtaca gcttcagctg tctggggatg cagaaccgag 1440
actttgttga gggagtgaat ggtgttgagt ggatcgatgt cgttctggaa ggaggctcat 1500actttgttga gggagtgaat ggtgttgagt ggatcgatgt cgttctggaa ggaggctcat 1500
gcgtaactat tacggcaaaa gacaggccga ccatagacgt caagatgatg aacatggagg 1560gcgtaactat tacggcaaaa gacaggccga ccatagacgt caagatgatg aacatggagg 1560
ctacggaatt agcggttgtg agatcttact gctatgagcc gaaagtgtcg gacgtgacga 1620ctacggaatt agcggttgtg agatcttact gctatgagcc gaaagtgtcg gacgtgacga 1620
cagaatccag atgcccaacc atgggagagg ctcataatcc caaggcaact tatgctgaat 1680cagaatccag atgcccaacc atgggagagg ctcataatcc caaggcaact tatgctgaat 1680
acatatgcaa aaaagatttt gtggacaggg gttggggcaa tggctgtggc ttgtttggaa 1740acatatgcaa aaaagatttt gtggacaggg gttggggcaa tggctgtggc ttgtttggaa 1740
aggggagcat ccagacatgt gccaagtttg actgcacaaa gaaagcagaa ggcaggatcg 1800aggggagcat ccagacatgt gccaagtttg actgcacaaa gaaagcagaa ggcaggatcg 1800
tgcagaagga aaacgtccag tttgaagttg cagtttttat acatggttcc acggaagcga 1860tgcagaagga aaacgtccag tttgaagttg cagtttttat acatggttcc acggaagcga 1860
gcacctacca caattattca gcccagcagt cgctgaaaca tgccgctaga ttcgtgataa 1920gcacctacca caattattca gcccagcagt cgctgaaaca tgccgctaga ttcgtgataa 1920
cgcccaaaag tcccgtctac actgctgaga tggaggatta tggtaccgtc acactcgaat 1980cgcccaaaag tcccgtctac actgctgaga tggaggatta tggtaccgtc acactcgaat 1980
gcgaaccccg atctggggtt gacatggggc aattctacgt cttcaccatg aatacaaaga 2040gcgaaccccg atctggggtt gacatggggc aattctacgt cttcaccatg aatacaaaga 2040
gctggcttgt taacagagac tggtttcatg acctcaactt accatggaca gggtcatcag 2100gctggcttgt taacagagac tggtttcatg acctcaactt accatggaca gggtcatcag 2100
cggggacgtg gcaaaacaaa gagtcattga tagaatttga ggaggctcat gccaccaaac 2160cggggacgtg gcaaaacaaa gagtcattga tagaatttga ggaggctcat gccaccaaac 2160
aatcagtggt ggctttggca tcacaagaag gagccctcca tgcagcattg gcgggagcta 2220aatcagtggt ggctttggca tcacaagaag gagccctcca tgcagcattg gcgggagcta 2220
ttccagtgaa gtactctgga aacaaattgg aaatgacctc aggtcatctt aaatgcaggg 2280ttccagtgaa gtactctgga aacaaattgg aaatgacctc aggtcatctt aaatgcaggg 2280
tcaaaatgca gggtttgaag ctgaaaggaa tgacctaccc gatgtgtagc aatacatttt 2340tcaaaatgca gggtttgaag ctgaaaggaa tgacctaccc gatgtgtagc aatacatttt 2340
ccctagtgaa gaatcctacc gacactgggc atggcactgt cgtggtggaa ttgtcttatg 2400ccctagtgaa gaatcctacc gacactgggc atggcactgt cgtggtggaa ttgtcttatg 2400
caggtaccga tgggccctgt agagttccca tatccatgtc ggcagatttg aatgacatga 2460caggtaccga tgggccctgt agagttccca tatccatgtc ggcagatttg aatgacatga 2460
caccagttgg acgcttgata acagtcaacc catacgtgtc gacttcctcc acgggtgcca 2520caccagttgg acgcttgata acagtcaacc catacgtgtc gacttcctcc acgggtgcca 2520
agataatggt ggaagtggaa cctccattcg gggattcatt tattttagta ggaagtggaa 2580agataatggt ggaagtggaa cctccattcg gggattcatt tattttagta ggaagtggaa 2580
aaggacagat taggtaccag tggcatagaa gtgggagtac aattggaaaa gctttcacgt 2640aaggacagat taggtaccag tggcatagaa gtgggagtac aattggaaaa gctttcacgt 2640
caacactcaa aggagcacaa aggatggttg ctttgggtga cactgcatgg gattttggtt 2700caacactcaa aggagcacaa aggatggttg ctttgggtga cactgcatgg gattttggtt 2700
cagttggggg tgtactcact tccattggga aaggcattca tcaagtcttc ggctcagcat 2760cagttggggg tgtactcact tccattggga aaggcattca tcaagtcttc ggctcagcat 2760
ttaaaagctt atttggagga atgtcatgga ttactcaagg catgttaggg gcactgctat 2820ttaaaagctt atttggagga atgtcatgga ttactcaagg catgttaggg gcactgctat 2820
tgtggatggg cctgaatgca agggacagat ccatttctat gacctttcta gtcgtaggag 2880tgtggatggg cctgaatgca agggacagat ccatttctat gacctttcta gtcgtaggag 2880
gaattttagt cttcttggca gtaaatgtca atgccgacac ggggtgctca atcgacttgg 2940gaattttagt cttcttggca gtaaatgtca atgccgacac ggggtgctca atcgacttgg 2940
ctaggaaaga attaaaatgt ggacaaggca tgtttgtctt caacgatgtt gaggcctgga 3000ctaggaaaga attaaaatgt ggacaaggca tgtttgtctt caacgatgtt gaggcctgga 3000
aggataatta caagtactat ccatccacac caaggagact tgccaaagtc gtggcaaaag 3060aggataatta caagtactat ccatccacac caaggagact tgccaaagtc gtggcaaaag 3060
ctcatgaggc tggaatttgt ggcatacgat cagtcagcag gctcgaggta agtatcaagg 3120ctcatgaggc tggaatttgt ggcatacgat cagtcagcag gctcgaggta agtatcaagg 3120
ttaca 3125ttaca 3125
<210> 8<210> 8
<211> 14327<211> 14327
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 8<400> 8
gtcgacgcgg ccgcgctagc gatgaccctg ctgattggtt cgctgaccat ttccgggtgc 60gtcgacgcgg ccgcgctagc gatgaccctg ctgattggtt cgctgaccat ttccgggtgc 60
gggacggcgt taccagaaac tcagaaggtt cgtccaacca aaccgactct gacggcagtt 120gggacggcgt taccagaaac tcagaaggtt cgtccaacca aaccgactct gacggcagtt 120
tacgagagag atgatagggt ctgcatcagt aagccagatg ctacacaatt aggcttgtac 180tacgagagag atgatagggt ctgcatcagt aagccagatg ctacacaatt aggcttgtac 180
atattgtcgt tagaacgcgg ctacaattaa tacataacct tatgtatcat acacatacga 240atattgtcgt tagaacgcgg ctacaattaa tacataacct tatgtatcat acacatacga 240
cgcgttggag ttccgcgtta cataacttac ggtaaatggc ccgcctggct gaccgcccaa 300cgcgttggag ttccgcgtta cataacttac ggtaaatggc ccgcctggct gaccgcccaa 300
cgacccccgc ccattgacgt caataatgac gtatgttccc atagtaacgc caatagggac 360cgacccccgc ccattgacgt caataatgac gtatgttccc atagtaacgc caatagggac 360
tttccattga cgtcaatggg tggagtattt acggtaaact gcccacttgg cagtacatca 420tttccattga cgtcaatggg tggagtattt acggtaaact gcccacttgg cagtacatca 420
agtgtatcat atgccaagta cgccccctat tgacgtcaat gacggtaaat ggcccgcctg 480agtgtatcat atgccaagta cgccccctat tgacgtcaat gacggtaaat ggcccgcctg 480
gcattatgcc cagtacatga ccttatggga ctttcctact tggcagtaca tctacgtatt 540gcattatgcc cagtacatga ccttatggga ctttcctact tggcagtaca tctacgtatt 540
agtcatcgct attaccatgg tgatgcggtt ttggcagtac atcaatgggc gtggatagcg 600agtcatcgct attaccatgg tgatgcggtt ttggcagtac atcaatgggc gtggatagcg 600
gtttgactca cggggatttc caagtctcca ccccattgac gtcaatggga gtttgttttg 660gtttgactca cggggatttc caagtctcca ccccattgac gtcaatggga gtttgttttg 660
gcaccaaaat caacgggact ttccaaaatg tcgtaacaac tccgccccat tgacgcaaat 720gcaccaaaat caacgggact ttccaaaatg tcgtaacaac tccgccccat tgacgcaaat 720
gggcggtagg cgtgtacggt gggaggtcta tataagcaga gctggtttag tgaaccgtag 780gggcggtagg cgtgtacggt gggaggtcta tataagcaga gctggtttag tgaaccgtag 780
aagttcatct gtgtgaactt attccaaaca gttttttggg atagtgcgtg tgaacgtaaa 840aagttcatct gtgtgaactt attccaaaca gttttttggg atagtgcgtg tgaacgtaaa 840
cacagtttga acgttttttg gatagagaca actatgtcta acaaaaaacc aggaagaccc 900cacagtttga acgtttttttg gatagagaca actatgtcta acaaaaaacc aggaagaccc 900
ggctcaggcc gggttgtcaa tatgctaaag cgcggaacgt cccgcggaaa tccgctagcg 960ggctcaggcc gggttgtcaa tatgctaaag cgcggaacgt cccgcggaaa tccgctagcg 960
cggataaaga ggacgattga tggggtcctg agaggagcag gacccataag gtttgtgctg 1020cggataaaga ggacgattga tggggtcctg agaggagcag gacccataag gtttgtgctg 1020
gctctactga ctttcttcaa gtttacagcc ctgaggccaa ccaataagcg gaaggcgaaa 1080gctctactga ctttcttcaa gtttacagcc ctgaggccaa ccaataagcg gaaggcgaaa 1080
cgtcgggggg ggagttgctc ttgggtcatc atgttactcc cgatagttgc tgggctgaaa 1140cgtcgggggg ggagttgctc ttgggtcatc atgttactcc cgatagttgc tgggctgaaa 1140
cttggaaatt ataatggtag agttttggcc actttaaaca agactgatgt gtcagacttg 1200cttggaaatt ataatggtag agttttggcc actttaaaca agactgatgt gtcagacttg 1200
ctagtcattc caacaacggc tggcagcaat ggatgcgtcg tgcgagctct agatgtggga 1260ctagtcattc caacaacggc tggcagcaat ggatgcgtcg tgcgagctct agatgtggga 1260
ctgatgtgtc aggatgacat aacgtacctg tgcccaaagt tggagtacgg ctatgaacct 1320ctgatgtgtc aggatgacat aacgtacctg tgcccaaagt tggagtacgg ctatgaacct 1320
gaagacatag actgctggtg caatgagact gagatataca ttcattatgg gagatgtacc 1380gaagacatag actgctggtg caatgagact gagatataca ttcattatgg gagatgtacc 1380
ccttcacggc atggacggag gtctaggagg tcggtgaacg tgcatcacca tggagagagt 1440ccttcacggc atggacggag gtctaggagg tcggtgaacg tgcatcacca tggagagagt 1440
ctacttgagg ccaagaacac gccgtggatg gattcgacca aagccactaa atatctcaca 1500ctacttgagg ccaagaacac gccgtggatg gattcgacca aagccactaa atatctcaca 1500
aaggttgaga actgggcgtt gagaaatcct gggtacgccc ttgctgccat cttcataggc 1560aaggttgaga actgggcgtt gagaaatcct gggtacgccc ttgctgccat cttcataggc 1560
tggaacttgg gaacgacgag aagccagaag ataattttca caattatgtt aatgttaatt 1620tggaacttgg gaacgacgag aagccagaag ataattttca caattatgtt aatgttaatt 1620
gccccagcgt acagcttcag ctgtctgggg atgcagaacc gagactttgt tgagggagtg 1680gccccagcgt acagcttcag ctgtctgggg atgcagaacc gagactttgt tgagggagtg 1680
aatggtgttg agtggatcga tgtcgttctg gaaggaggct catgcgtaac tattacggca 1740aatggtgttg agtggatcga tgtcgttctg gaaggaggct catgcgtaac tattacggca 1740
aaagacaggc cgaccataga cgtcaagatg atgaacatgg aggctacgga attagcggtt 1800aaagacaggc cgaccataga cgtcaagatg atgaacatgg aggctacgga attagcggtt 1800
gtgagatctt actgctatga gccgaaagtg tcggacgtga cgacagaatc cagatgccca 1860gtgagatctt actgctatga gccgaaagtg tcggacgtga cgacagaatc cagatgccca 1860
accatgggag aggctcataa tcccaaggca acttatgctg aatacatatg caaaaaagat 1920accatgggag aggctcataa tcccaaggca acttatgctg aatacatatg caaaaaagat 1920
tttgtggaca ggggttgggg caatggctgt ggcttgtttg gaaaggggag catccagaca 1980tttgtggaca ggggttgggg caatggctgt ggcttgtttg gaaagggggag catccagaca 1980
tgtgccaagt ttgactgcac aaagaaagca gaaggcagga tcgtgcagaa ggaaaacgtc 2040tgtgccaagt ttgactgcac aaagaaagca gaaggcagga tcgtgcagaa ggaaaacgtc 2040
cagtttgaag ttgcagtttt tatacatggt tccacggaag cgagcaccta ccacaattat 2100cagtttgaag ttgcagtttt tatacatggt tccacggaag cgagcaccta ccacaattat 2100
tcagcccagc agtcgctgaa acatgccgct agattcgtga taacgcccaa aagtcccgtc 2160tcagcccagc agtcgctgaa acatgccgct agattcgtga taacgcccaa aagtcccgtc 2160
tacactgctg agatggagga ttatggtacc gtcacactcg aatgcgaacc ccgatctggg 2220tacactgctg agatggagga ttatggtacc gtcacactcg aatgcgaacc ccgatctggg 2220
gttgacatgg ggcaattcta cgtcttcacc atgaatacaa agagctggct tgttaacaga 2280gttgacatgg ggcaattcta cgtcttcacc atgaatacaa agagctggct tgttaacaga 2280
gactggtttc atgacctcaa cttaccatgg acagggtcat cagcggggac gtggcaaaac 2340gactggtttc atgacctcaa cttaccatgg acagggtcat cagcggggac gtggcaaaac 2340
aaagagtcat tgatagaatt tgaggaggct catgccacca aacaatcagt ggtggctttg 2400aaagagtcat tgatagaatt tgaggaggct catgccacca aacaatcagt ggtggctttg 2400
gcatcacaag aaggagccct ccatgcagca ttggcgggag ctattccagt gaagtactct 2460gcatcacaag aaggagccct ccatgcagca ttggcgggag ctattccagt gaagtactct 2460
ggaaacaaat tggaaatgac ctcaggtcat cttaaatgca gggtcaaaat gcagggtttg 2520ggaaacaaat tggaaatgac ctcaggtcat cttaaatgca gggtcaaaat gcagggtttg 2520
aagctgaaag gaatgaccta cccgatgtgt agcaatacat tttccctagt gaagaatcct 2580aagctgaaag gaatgaccta cccgatgtgt agcaatacat tttccctagt gaagaatcct 2580
accgacactg ggcatggcac tgtcgtggtg gaattgtctt atgcaggtac cgatgggccc 2640accgacactg ggcatggcac tgtcgtggtg gaattgtctt atgcaggtac cgatgggccc 2640
tgtagagttc ccatatccat gtcggcagat ttgaatgaca tgacaccagt tggacgcttg 2700tgtagagttc ccatatccat gtcggcagat ttgaatgaca tgacaccagt tggacgcttg 2700
ataacagtca acccatacgt gtcgacttcc tccacgggtg ccaagataat ggtggaagtg 2760ataacagtca acccatacgt gtcgacttcc tccacgggtg ccaagataat ggtggaagtg 2760
gaacctccat tcggggattc atttatttta gtaggaagtg gaaaaggaca gattaggtac 2820gaacctccat tcggggattc atttatttta gtaggaagtg gaaaaggaca gattaggtac 2820
cagtggcata gaagtgggag tacaattgga aaagctttca cgtcaacact caaaggagca 2880cagtggcata gaagtgggag tacaattgga aaagctttca cgtcaacact caaaggagca 2880
caaaggatgg ttgctttggg tgacactgca tgggattttg gttcagttgg gggtgtactc 2940caaaggatgg ttgctttggg tgacactgca tgggattttg gttcagttgg gggtgtactc 2940
acttccattg ggaaaggcat tcatcaagtc ttcggctcag catttaaaag cttatttgga 3000acttccattg ggaaaggcat tcatcaagtc ttcggctcag catttaaaag cttatttgga 3000
ggaatgtcat ggattactca aggcatgtta ggggcactgc tattgtggat gggcctgaat 3060ggaatgtcat ggattactca aggcatgtta ggggcactgc tattgtggat gggcctgaat 3060
gcaagggaca gatccatttc tatgaccttt ctagtcgtag gaggaatttt agtcttcttg 3120gcaagggaca gatccatttc tatgaccttt ctagtcgtag gaggaatttt agtcttcttg 3120
gcagtaaatg tcaatgccga cacggggtgc tcaatcgact tggctaggaa agaattaaaa 3180gcagtaaatg tcaatgccga cacggggtgc tcaatcgact tggctaggaa agaattaaaa 3180
tgtggacaag gcatgtttgt cttcaacgat gttgaggcct ggaaggataa ttacaagtac 3240tgtggacaag gcatgtttgt cttcaacgat gttgaggcct ggaaggataa ttacaagtac 3240
tatccatcca caccaaggag acttgccaaa gtcgtggcaa aagctcatga ggctggaatt 3300tatccatcca caccaaggag acttgccaaa gtcgtggcaa aagctcatga ggctggaatt 3300
tgtggcatac gatcagtcag caggctcgag gtaagtatca aggttacaag gcaggtttaa 3360tgtggcatac gatcagtcag caggctcgag gtaagtatca aggttacaag gcaggtttaa 3360
ggagaccaat agaaactggg cttgtcgaga cagagaagac tcttgcgttt ctgataggca 3420ggagaccaat agaaactggg cttgtcgaga cagagaagac tcttgcgttt ctgataggca 3420
cctattggtc ttactgacat ccactttgcc tttctctcca cagcacaata tgtgggtaag 3480cctattggtc ttactgacat ccactttgcc tttctctcca cagcacaata tgtgggtaag 3480
catcaaacat gagttgaatg cgatcttgga agacaatgcc attgatttga ctgtggtggt 3540catcaaacat gagttgaatg cgatcttgga agacaatgcc attgatttga ctgtggtggt 3540
tgaagaaaat cctggaagat acaggaaaac caatcagagg ctgccgaacg ttgatggaga 3600tgaagaaaat cctggaagat acaggaaaac caatcagagg ctgccgaacg ttgatggaga 3600
gctcacgtac ggatggaaga aatgggggaa aagtattttt agcagcccga agatgtcaaa 3660gctcacgtac ggatggaaga aatgggggaa aagtattttt agcagcccga agatgtcaaa 3660
taatacattt gtcattgatg gaccaaaaac tagagagtgc ccagatgaga gaagagcatg 3720taatacattt gtcattgatg gaccaaaaac tagagagtgc ccagatgaga gaagagcatg 3720
gaatagcatg aaaattgaag actttgggtt tggagtgttg tccacaaagg tatggatgga 3780gaatagcatg aaaattgaag actttgggtt tggagtgttg tccacaaagg tatggatgga 3780
aatgcgaaca gaaaatacaa ctgattgtga caccgcagta atgggcacag caattaaagg 3840aatgcgaaca gaaaatacaa ctgattgtga caccgcagta atgggcacag caattaaagg 3840
aaatagagct gtgcacagtg acctgagcta ttggatagag agcaagaata atggaagctg 3900aaatagagct gtgcacagtg acctgagcta ttggatagag agcaagaata atggaagctg 3900
gaaactggag agggctgtgt tgggcgaggt gaagtcatgc acatggccag aaacccacac 3960gaaactggag agggctgtgt tgggcgaggt gaagtcatgc acatggccag aaacccacac 3960
cctgtggagt gacagcgttg tggagagtga actcatcata cctaagacat tgggaggacc 4020cctgtggagt gacagcgttg tggagagtga actcatcata cctaagacat tgggaggacc 4020
gaagagtcat cacaacacga ggacaggata cagggttcag agttccggac cgtgggatga 4080gaagagtcat cacaacacga ggacaggata cagggttcag agttccggac cgtgggatga 4080
gaaagagatt gcaatagact tcgactactg tcctggaaca actgtcacag taacgagctc 4140gaaagagatt gcaatagact tcgactactg tcctggaaca actgtcacag taacgagctc 4140
gtgccgcgac agagggcctt cagctaggac aacaacagcg agtgggaaat tgataacaga 4200gtgccgcgac agagggcctt cagctaggac aacaacagcg agtgggaaat tgataacaga 4200
ttggtgttgt aggtcttgca ccatcccacc actgagattt gttacaaaaa gtggatgctg 4260ttggtgttgt aggtcttgca ccatcccacc actgagattt gttacaaaaa gtggatgctg 4260
gtatgggatg gaaattcggc caattgttca cggagacgac atgttgatca aatcaaaggt 4320gtatgggatg gaaattcggc caattgttca cggagacgac atgttgatca aatcaaaggt 4320
catggctttt caagggggtg gcatggaacc tatgcaatta gggatgctcg ttatgattgt 4380catggctttt caagggggtg gcatggaacc tatgcaatta gggatgctcg ttatgattgt 4380
agcagcccag gagattttga gaaggcgcat gacggctcca attgcttggt cagcgctgct 4440agcagcccag gagattttga gaaggcgcat gacggctcca attgcttggt cagcgctgct 4440
gttgctgatg gctttggtcc tgtttggagg aatcacgtac agtgatctgg tcaagtacgt 4500gttgctgatg gctttggtcc tgtttggagg aatcacgtac agtgatctgg tcaagtacgt 4500
catcctagtg gcagctgcat ttgctgagag caatacaggt ggtgacattg tgcacttggc 4560catcctagtg gcagctgcat ttgctgagag caatacaggt ggtgacattg tgcacttggc 4560
catggtggct gcttttaaca ttcagccagg tttactgatt ggatttttac tgaggaggaa 4620catggtggct gcttttaaca ttcagccagg tttactgatt ggatttttac tgaggaggaa 4620
gtggagcaat caggaaagca gattgcttgg cgttgcgtta gcactcataa cagtggcgat 4680gtggagcaat caggaaagca gattgcttgg cgttgcgtta gcactcataa cagtggcgat 4680
gagagacttg aacatgagta taccaacatt actaaactcc ggagccatgg cctggctctt 4740gagagacttg aacatgagta taccaacatt actaaactcc ggagccatgg cctggctctt 4740
gctgagagcc gtgtttgaag ggacggttag ctcctttgcc ctgccgcttg ttagcttgct 4800gctgagagcc gtgtttgaag ggacggttag ctcctttgcc ctgccgcttg ttagcttgct 4800
ggctccagga ctcagaatag tggggataga tgtggtgagg ataggtgtgc taaccctggg 4860ggctccagga ctcagaatag tggggataga tgtggtgagg ataggtgtgc taaccctggg 4860
gatcctctca ctattgaaag agaggagcaa cgcaatggca aaaaagaagg gaggcatgct 4920gatcctctca ctattgaaag agaggagcaa cgcaatggca aaaaagaagg gaggcatgct 4920
cctgggagtg gcatgcgcta ccgctggaat cgctagccct ttggtgtttg ctggtctgca 4980cctgggagtg gcatgcgcta ccgctggaat cgctagccct ttggtgtttg ctggtctgca 4980
catggtgctg aagccagtga cacggagagg gtggccagtc agtgaggctt tgactgctgt 5040catggtgctg aagccagtga cacggagagg gtggccagtc agtgaggctt tgactgctgt 5040
gggattgaca ttcgcgttgg caggaggaat agcccagttt gatgacagca gcatggcgat 5100gggattgaca ttcgcgttgg caggaggaat agcccagttt gatgacagca gcatggcgat 5100
tccattagcc gttggcggga tcatgctggt ggtggcagtg gtgacaggct tctctacaga 5160tccattagcc gttggcggga tcatgctggt ggtggcagtg gtgacaggct tctctacaga 5160
cttatggcta gagaaagcga gcgacatctc gtggagtgag gaggcgaggg tgactggagc 5220cttatggcta gagaaagcga gcgacatctc gtggagtgag gaggcgaggg tgactggagc 5220
atcacagaga tttgatgtgg aaattgatca ggacggcaat atgagattgc tgaacgatcc 5280atcacagaga tttgatgtgg aaattgatca ggacggcaat atgagattgc tgaacgatcc 5280
tggtgtgtcg ctcggcgttt gggcctttcg aactgggctt attctgctat cttcatacaa 5340tggtgtgtcg ctcggcgttt gggcctttcg aactgggctt attctgctat cttcatacaa 5340
cccatatttc ctgccattga ctctggcagg ttactggatg acaactaagg caaaacaacg 5400cccatatttc ctgccattga ctctggcagg ttactggatg acaactaagg caaaacaacg 5400
aggaggagtc atctgggatg tgccagctcc aaaggaaagg aagagagccg aagtaggcaa 5460aggaggagtc atctgggatg tgccagctcc aaaggaaagg aagagagccg aagtaggcaa 5460
tggagttttc cgaattatgg caagaggact gttaggaaaa taccaggctg gggtgggagt 5520tggagttttc cgaattatgg caagaggact gttaggaaaa taccaggctg gggtgggagt 5520
catgcatgag ggagtgtttc acaccatgtg gcacgtgacg aacggggccg ttatccaagc 5580catgcatgag ggagtgtttc acaccatgtg gcacgtgacg aacggggccg ttatccaagc 5580
aggagaagga acactggtcc catattgggc gagtgtacgc aatgatctga tttcctatgg 5640aggagaagga acactggtcc catattgggc gagtgtacgc aatgatctga tttcctatgg 5640
tggaccatgg aaattgggga agcaatggaa tggtgtagat gaagtgcaag tcatcgtcgt 5700tggaccatgg aaattgggga agcaatggaa tggtgtagat gaagtgcaag tcatcgtcgt 5700
gcaaccaggc aaagaggtca taaacgtgca gactcagcca ggaattttca agactcaata 5760gcaaccaggc aaagaggtca taaacgtgca gactcagcca ggaattttca agactcaata 5760
tggtgaagtt ggagctgtgt ccctcgatta cccaacggga acctctggat cacctattat 5820tggtgaagtt ggagctgtgt ccctcgatta cccaacggga acctctggat cacctattat 5820
tgacaaggaa ggacaggtgg ttggcctcta tggtaatgga attctggtgg gttcaggcga 5880tgacaaggaa ggacaggtgg ttggcctcta tggtaatgga attctggtgg gttcaggcga 5880
ttttgtcagc atgattactc aaggggagaa gaaggaggaa gaagttcctc aggtgtttga 5940ttttgtcagc atgattactc aaggggagaa gaaggaggaa gaagttcctc aggtgtttga 5940
cgaaaacatg ctgcggaaaa ggcaactgac agttctggac ctacatccag gttcaggaaa 6000cgaaaacatg ctgcggaaaa ggcaactgac agttctggac ctacatccag gttcaggaaa 6000
gaccagaaag gtcctcccca tgattctgaa gagcgccatt gacaaacgat taagaacagc 6060gaccagaaag gtcctcccca tgattctgaa gagcgccatt gacaaacgat taagaacagc 6060
tgtcttggct ccgacgcggg tggtggccgc tgaaatagcg gaagcactga aaggactccc 6120tgtcttggct ccgacgcggg tggtggccgc tgaaatagcg gaagcactga aaggactccc 6120
aatacggtat ctgactccgg cagtaaagag ggagcatact ggaacagaga taatagatgt 6180aatacggtat ctgactccgg cagtaaagag ggagcatact ggaacagaga taatagatgt 6180
gatgtgtcac gcgactttga cagcgcggct gctcacacct cagcgagtgc cgaattacaa 6240gatgtgtcac gcgactttga cagcgcggct gctcacacct cagcgagtgc cgaattacaa 6240
cctgttcatt atggatgagg ctcacttcac agaccctgcc agcattgctg ccagaggata 6300cctgttcatt atggatgagg ctcacttcac agaccctgcc agcattgctg ccagaggata 6300
catatcaaca aaggtggaac tgggagaggc agctgcaata ttcatgacag ccacacctcc 6360catatcaaca aaggtggaac tgggagaggc agctgcaata ttcatgacag ccacacctcc 6360
aggtacaact gaggcatttc cggactccaa ctcgccaata acagacattg aagagcaaat 6420aggtacaact gaggcatttc cggactccaa ctcgccaata acagacattg aagagcaaat 6420
ccctgacaga gcttggaatt ctgggtatga gtggataaca gactttcaag gaaagactgt 6480ccctgacaga gcttggaatt ctgggtatga gtggataaca gactttcaag gaaagactgt 6480
atggtttgtc cccagcgtga agtctggtaa tgagatcgcc gtgtgcttga caaaggccgg 6540atggtttgtc cccagcgtga agtctggtaa tgagatcgcc gtgtgcttga caaaggccgg 6540
taagaaggta attcagttaa ataggaagag ttttgactca gagtatccta agtgcaagag 6600taagaaggta attcagttaa ataggaagag ttttgactca gagtatccta agtgcaagag 6600
tggagaatgg gatttcgtga taaccactga catctcagaa atgggagcga actttggagc 6660tggagaatgg gatttcgtga taaccactga catctcagaa atgggagcga actttggagc 6660
gcaacgggtc atagatagtc ggaagtgcat taaaccagtg attattgagg atggagaagg 6720gcaacgggtc atagatagtc ggaagtgcat taaaccagtg attattgagg atggagaagg 6720
aagtgtgcaa atgaatggac cagttccaat aacatcagcc agtgcagccc agcgtcgtgg 6780aagtgtgcaa atgaatggac cagttccaat aacatcagcc agtgcagccc agcgtcgtgg 6780
acgggttgga agggatgtga cacaaattgg agatgagtac cactactcag gaccaaccag 6840acgggttgga agggatgtga cacaaattgg agatgagtac cactactcag gaccaaccag 6840
cgaggatgat catgatttcg ctcattggaa agaggccaag atactgctgg acaacattaa 6900cgaggatgat catgatttcg ctcattggaa agaggccaag atactgctgg acaacattaa 6900
catgccagat gggctggttg cccagttgta cggcccagag cgggacaagg ttgacgcaat 6960catgccagat gggctggttg cccagttgta cggcccagag cgggacaagg ttgacgcaat 6960
tgatggggaa ttcagactga ggactgagca gaggaaacac tttgtggagt atctgaggac 7020tgatggggaa ttcagactga ggactgagca gaggaaacac tttgtggagt atctgaggac 7020
aggagacctc cctgtctgga tatcgtacaa ggtcgctgaa gctgggataa gttacaatga 7080aggagacctc cctgtctgga tatcgtacaa ggtcgctgaa gctgggataa gttacaatga 7080
ccggcggtgg tgctttgatg gaccctcatg caatactgtt ctggaggaca ataacccagt 7140ccggcggtgg tgctttgatg gaccctcatg caatactgtt ctggaggaca ataacccagt 7140
ggagttatgg acaaagtcag gtgagaagaa aatcttgaag ccccggtgga gagatggaag 7200ggagttatgg acaaagtcag gtgagaagaa aatcttgaag ccccggtgga gagatggaag 7200
attgtgggca gatcaccagg ccttaaaagc cttcaaggat tttgcgagtg gaaagagatc 7260attgtgggca gatcaccagg ccttaaaagc cttcaaggat tttgcgagtg gaaagagatc 7260
agcgataggg atccttgagg tcttcaggat gcttcccgat cacttcgctc acagaatgac 7320agcgataggg atccttgagg tcttcaggat gcttcccgat cacttcgctc acagaatgac 7320
agaatccatg gacaacatat acatgctgac tacagctgag aaagggagta gggcccacag 7380agaatccatg gacaacatat acatgctgac tacagctgag aaagggagta gggcccacag 7380
agaagccctg gaggaactgc ctgagacact tgaaacattt ttactggtgt tcatgatgac 7440agaagccctg gaggaactgc ctgagacact tgaaacattt ttactggtgt tcatgatgac 7440
agtcgcctct atgggggtgt tcttgttctt tgttcagagg agaggtttag ggaagacagg 7500agtcgcctct atgggggtgt tcttgttctt tgttcagagg agaggtttag ggaagacagg 7500
tcttggagcc atggtcatgg ccacagtcac ggttttgtta tggatagcag aagtcccagc 7560tcttggagcc atggtcatgg ccacagtcac ggttttgtta tggatagcag aagtcccagc 7560
ccagaagatt gccggtgtgc tcctagtttc tctattgctg atgattgttc tgatcccaga 7620ccagaagatt gccggtgtgc tcctagtttc tctattgctg atgattgttc tgatcccaga 7620
accagagaga cagagatcac agacggatag tcacttggct gttttcatga ttgttgtctt 7680accagagaga cagagatcac agacggatag tcacttggct gttttcatga ttgttgtctt 7680
gttagtggtg ggtgctgtgg cgtcaaatga aatgggttgg ctagagcaaa caaagaagga 7740gttagtggtg ggtgctgtgg cgtcaaatga aatgggttgg ctagagcaaa caaagaagga 7740
cttgtcagct ctgtttggga gaaaaagcga aagccatcaa gaaacctgga gtatgccttg 7800cttgtcagct ctgtttggga gaaaaagcga aagccatcaa gaaacctgga gtatgccttg 7800
gccggatttg agaccagcga cggcatgggc ggcctacgca ggagctacaa catttctgac 7860gccggatttg agaccagcga cggcatgggc ggcctacgca ggagctacaa catttctgac 7860
tcccttgcta aaacacctca taataacaga gtatgtgaat ttttcactca tggcaatgac 7920tcccttgcta aaacacctca taataacaga gtatgtgaat ttttcactca tggcaatgac 7920
ggcgcaggct ggagcactat ttggactagg gaaaggcatg ccttttgtca aagcagactt 7980ggcgcaggct ggagcactat ttggactagg gaaaggcatg ccttttgtca aagcagactt 7980
gtcagtaccc ctgctactct tagggtgttg gggacagttc acaatgacaa caacggtctc 8040gtcagtaccc ctgctactct tagggtgttg gggacagttc acaatgacaa caacggtctc 8040
ggcagtcatg atggtcatac tgcattatgc atttttggtg ccaggttggc aagcagaagc 8100ggcagtcatg atggtcatac tgcattatgc atttttggtg ccaggttggc aagcagaagc 8100
catgaggtcg gcccagagga gaactgctgc aggtgtgatg aaaaatcccg tggttgatgg 8160catgaggtcg gcccagagga gaactgctgc aggtgtgatg aaaaatcccg tggttgatgg 8160
catagtggct acagatgttc cagaccttga ggccagcact cctattacag aaaagaaatt 8220catagtggct acagatgttc cagaccttga ggccagcact cctattacag aaaagaaatt 8220
gggtcaatgc gtgctagtgg gaatagcctt ggtggcggtg tttctaacac caaacacgct 8280gggtcaatgc gtgctagtgg gaatagcctt ggtggcggtg tttctaacac caaacacgct 8280
aactttgact gagtttggaa tgttgacctc tgccgcttcg gtgacattaa ttgagggagc 8340aactttgact gagtttggaa tgttgacctc tgccgcttcg gtgacattaa ttgagggagc 8340
tgcaggtcgt atttggaacg caaccacagc cgttgctatg tgccatctgt tgaggaaaaa 8400tgcaggtcgt atttggaacg caaccacagc cgttgctatg tgccatctgt tgaggaaaaa 8400
ctggttggct ggggcctctc tagcatggac tataactcgg aatctccagg cagggacctt 8460ctggttggct ggggcctctc tagcatggac tataactcgg aatctccagg cagggacctt 8460
gcgtcgagga ggaggaactg gcagaacttt gggggaagca tggaaggccc agcttaacca 8520gcgtcgagga ggaggaactg gcagaacttt gggggaagca tggaaggccc agcttaacca 8520
actgacccgg caagagttta tggaataccg gaaagacggg attattgaag tagatagagc 8580actgacccgg caagagttta tggaataccg gaaagacggg attattgaag tagatagagc 8580
tgctgcaaaa agagcccgcc gtgaaggaaa tgtgacagga gggcacccag tttcacgagg 8640tgctgcaaaa agagcccgcc gtgaaggaaa tgtgacagga gggcacccag tttcacgagg 8640
cacggcaaag ttgaggtggc tcgtggagcg tgggtttctc aaaccaagag gcaaagttgt 8700cacggcaaag ttgaggtggc tcgtggagcg tgggtttctc aaaccaagag gcaaagttgt 8700
ggatttaggc tgcggcagag gaggctggag ttactactgt gctacattaa agcaggttca 8760ggatttaggc tgcggcagag gaggctggag ttactactgt gctacattaa agcaggttca 8760
ggaagtgaga ggttacacaa aaggagggcc agggcatgag gaaccagtga tgacccagag 8820ggaagtgaga ggttacacaa aaggagggcc agggcatgag gaaccagtga tgacccagag 8820
ctatggctgg aacattgtga cgttaaagag tggggttaat gttcatttca agccgactga 8880ctatggctgg aacattgtga cgttaaagag tggggttaat gttcatttca agccgactga 8880
accatctgac acactgctat gtgacatagg tgaagcttca cccgtcccag aaattgaatc 8940accatctgac acactgctat gtgacatagg tgaagcttca cccgtcccag aaattgaatc 8940
tgccagaaca atcagggtgc tgcaaatggc cgaggaatgg ttagctaggg gcgttgaaga 9000tgccagaaca atcagggtgc tgcaaatggc cgaggaatgg ttagctaggg gcgttgaaga 9000
gttctgcata aaagtgcttt gtccctacat gccagcggtc ataaaagaac tggaaagact 9060gttctgcata aaagtgcttt gtccctacat gccagcggtc ataaaagaac tggaaagact 9060
gcagctgaaa tggggaggtg gtttggtcag agtgccactc tcgcgtaatt caacgcatga 9120gcagctgaaa tggggaggtg gtttggtcag agtgccactc tcgcgtaatt caacgcatga 9120
gatgtactgg gtgagcggct caagtgggaa tgtgacaaat agtattaata cagtgagcca 9180gatgtactgg gtgagcggct caagtgggaa tgtgacaaat agtattaata cagtgagcca 9180
aatgctgatc aacaggatgc acaaaaccaa ccgtaatgga cccaggtatg aagaagatgt 9240aatgctgatc aacaggatgc acaaaaccaa ccgtaatgga cccaggtatg aagaagatgt 9240
ggacttgggt tcagggacca gagctgtgag ctgcacaaga cagaggactg actggggaat 9300ggacttgggt tcagggacca gagctgtgag ctgcacaaga cagaggactg actggggaat 9300
ggtcgctgat agggtgaaga atttggccag agaatatgct ccgtcttggc attatgacca 9360ggtcgctgat agggtgaaga atttggccag agaatatgct ccgtcttggc attatgacca 9360
agacaatcct tacaagactt ggaactatca tggaagttac gaagtgaaag ccacaggctc 9420agacaatcct tacaagactt ggaactatca tggaagttac gaagtgaaag ccacaggctc 9420
agccagctca atggttaatg gggtagttag gatactgtca aaaccttggg acaccttgca 9480agccagctca atggttaatg gggtagttag gatactgtca aaaccttggg acaccttgca 9480
aaacgtggtg aatatggcca tgacggacac tactcctttt gggcaacagc gcgtatttaa 9540aaacgtggtg aatatggcca tgacggacac tactcctttt gggcaacagc gcgtatttaa 9540
agaaaaggtt gataccaaag ccccagaacc acctgcagga acagctaggg ttatgaacat 9600agaaaaggtt gataccaaag ccccagaacc acctgcagga acagctaggg ttatgaacat 9600
cgtggcaaga tggatgtgga actttgttgg caggaacaaa caaccaagga tgtgcacaaa 9660cgtggcaaga tggatgtgga actttgttgg caggaacaaa caaccaagga tgtgcacaaa 9660
agaagagttc atagagaagg tgaatagtaa cgcagccctg ggggccatgt ttgaggagca 9720agaagagttc atagagaagg tgaatagtaa cgcagccctg ggggccatgt ttgaggagca 9720
acacaaatgg gccagcgcca gggaagcggt tgaggatcct gaattttgga gtcttgttga 9780acacaaatgg gccagcgcca gggaagcggt tgaggatcct gaattttgga gtcttgttga 9780
cagagagaga gaactgcact tgcaagggaa gtgcgagacc tgcatttaca acatgatggg 9840cagagagaga gaactgcact tgcaagggaa gtgcgagacc tgcatttaca acatgatggg 9840
aaagcgagaa aagaagatgg gagagttcgg gaaagcaaaa ggtagcagag ctatttggta 9900aaagcgagaa aagaagatgg gagagttcgg gaaagcaaaa ggtagcagag ctatttggta 9900
catgtggctc ggggccagat tcctagagtt cgaagccttg ggcttcttga acgaggatca 9960catgtggctc ggggccagat tcctagagtt cgaagccttg ggcttcttga acgaggatca 9960
ctggatgagc agggaaaaca ctaaaggagg cgttgaagga cttggactcc aaaagttggg 10020ctggatgagc agggaaaaca ctaaaggagg cgttgaagga cttggactcc aaaagttgggg 10020
gtatgtgctg cgtgacattt cggccaaaga aggaggactt atgtacgcag acgacacggc 10080gtatgtgctg cgtgacattt cggccaaaga aggaggactt atgtacgcag acgacacggc 10080
cggatgggac actagaataa ccaaggctga tttggaaaac gaagccatca tcttggaaaa 10140cggatgggac actagaataa ccaaggctga tttggaaaac gaagccatca tcttggaaaa 10140
gatggaacca atgcacagag ctgttgcaga accactcatt aaatttgcct acatgaataa 10200gatggaacca atgcacagag ctgttgcaga accactcatt aaatttgcct acatgaataa 10200
ggtggtgaag gtgatgcgac cgggacgtga tgggaagaca gttatggatg tcatctcgcg 10260ggtggtgaag gtgatgcgac cgggacgtga tgggaagaca gttatggatg tcatctcgcg 10260
ggaagaccag aggggaagtg gacaggttgt gacctatgct ctcaacactt tcacgaacct 10320ggaagaccag aggggaagtg gacaggttgt gacctatgct ctcaacactt tcacgaacct 10320
gtgtgtccag ctcattagat gtatggaagg ggaggagctg ctgctccccg aggaaacaga 10380gtgtgtccag ctcattagat gtatggaagg ggaggagctg ctgctccccg aggaaacaga 10380
gcgtctaaaa aaaggaaagg agaagcgcat ccaagaatgg ctccaaaaga atggagagaa 10440gcgtctaaaa aaaggaaagg agaagcgcat ccaagaatgg ctccaaaaga atggagagaa 10440
caggttgtca gccatggcag tcagtgggga tgactgtgtg gtgaaaccag cggatgacag 10500caggttgtca gccatggcag tcagtgggga tgactgtgtg gtgaaaccag cggatgacag 10500
attcgccaca gcactgcact tcctcaatag tatgtctaag gtgaggaaag atactcagga 10560attcgccaca gcactgcact tcctcaatag tatgtctaag gtgaggaaag atactcagga 10560
atggaagccc tcaaccggtt ggagaaactg gcaagaagtc cccttttgct cacaccattt 10620atggaagccc tcaaccggtt ggagaaactg gcaagaagtc cccttttgct cacaccattt 10620
ccacgagctg caaatgaaag atggcagaaa gattgtggtt ccatgtcgag accaggatga 10680ccacgagctg caaatgaaag atggcagaaa gattgtggtt ccatgtcgag accaggatga 10680
gctaattgga agagccaggc tctctccagg gtctggctgg tcactaacag aaacagcatg 10740gctaattgga agagccaggc tctctccagg gtctggctgg tcactaacag aaacagcatg 10740
cctgagcaaa gcatatgctc agatgtggtt attgatgtac ttccacagga gggacctcag 10800cctgagcaaa gcatatgctc agatgtggtt attgatgtac ttccacagga gggacctcag 10800
actaatggca aacgccatct gctcatctgt ccctgtctca tgggtcccca caggaaggac 10860actaatggca aacgccatct gctcatctgt ccctgtctca tgggtcccca caggaaggac 10860
aacgtggtca atccatggaa aaggcgagtg gatgacttct gaagacatgc tggcagtgtg 10920aacgtggtca atccatggaa aaggcgagtg gatgacttct gaagacatgc tggcagtgtg 10920
gaacagggtg tggattgaag aaaatgaaca catggaagac aaaaccccag tgacttcatg 10980gaacagggtg tggattgaag aaaatgaaca catggaagac aaaaccccag tgacttcatg 10980
gaacgaagtg ccataccttg gaaagaggga agatggctgg tgtggtagtc tgattggaca 11040gaacgaagtg ccataccttg gaaagaggga agatggctgg tgtggtagtc tgattggaca 11040
ccgagccaga tctacctggg ccgagaacat atacactcca attatgcaga tcagagctct 11100ccgagccaga tctacctggg ccgagaacat atacactcca attatgcaga tcagagctct 11100
cattggccct gagcactatg tagattatat gccaactcta aataggttca aacccattga 11160cattggccct gagcactatg tagattatat gccaactcta aataggttca aacccattga 11160
aagctggagt gaaggtgttt tgtaaatata tgaggtaggt gtaaaaatgt atgtaaagta 11220aagctggagt gaaggtgttt tgtaaatata tgaggtaggt gtaaaaatgt atgtaaagta 11220
gtgttagtct agagtagata aatatataaa ttagcatttg tttgaataga taggaagagg 11280gtgttagtct agagtagata aatatataaa ttagcatttg tttgaataga taggaagagg 11280
aagtcaggcc agggaatccc tgccaccgga tgttggatga cggtgctgtc tgcgttccaa 11340aagtcaggcc agggaatccc tgccaccgga tgttggatga cggtgctgtc tgcgttccaa 11340
ccccaggagg actgggttaa caaatctggg tgcatggagg agctaagcgt tcaataccgc 11400ccccaggagg actgggttaa caaatctggg tgcatggagg agctaagcgt tcaataccgc 11400
ctcggagaac tccctggctc acgaagtgcc ctggaccagt gtcgggccac aggttttgtg 11460ctcggagaac tccctggctc acgaagtgcc ctggaccagt gtcgggccac aggttttgtg 11460
ccactagcgt gcagtgcagc ccggacaaaa gacacgcccc aggaggactg ggaaaacaaa 11520ccactagcgt gcagtgcagc ccggacaaaa gacacgcccc aggaggactg ggaaaacaaa 11520
gccgaaatgg cccccacggc ctgaaatgat ggagctggtg tgaccatcat ggagggacta 11580gccgaaatgg cccccacggc ctgaaatgat ggagctggtg tgaccatcat ggagggacta 11580
gaggttagag gagaccccgt ggaaagaaag caaggcccaa cctagagtca agctgtaact 11640gaggttagag gagaccccgt ggaaagaaag caaggcccaa cctagagtca agctgtaact 11640
ctaggggaag gactagaggt tagaggagac cccttgcgag tgagcaccac aagaaacagc 11700ctaggggaag gactagaggt tagaggagac cccttgcgag tgagcaccac aagaaacagc 11700
atattgacac ctgggataga ctaggagacc ctctgtccta acaacaccag ccacttggca 11760atattgacac ctgggataga ctaggagacc ctctgtccta acaacaccag ccacttggca 11760
cagatcgccg aaagtgtggc tggtggtggt agaacacagg atctgggtcg gcatggcatc 11820cagatcgccg aaagtgtggc tggtggtggt agaacacagg atctgggtcg gcatggcatc 11820
tccacctcct cgcggtccga cctgggctac ttcggtaggc taagggagaa gaacttgttt 11880tccacctcct cgcggtccga cctgggctac ttcggtaggc taagggagaa gaacttgttt 11880
attgcagctt ataatggtta caaataaagc aatagcatca caaatttcac aaataaagca 11940attgcagctt ataatggtta caaataaagc aatagcatca caaatttcac aaataaagca 11940
tttttttcac tgcattctag ttgtggtttg tccaaactca tcaatgtatc ttatcgcgac 12000tttttttcac tgcattctag ttgtggtttg tccaaactca tcaatgtatc ttatcgcgac 12000
aagacgtttc ccgttgaata tggctcataa caccccttgt attactgttt atgtaagcag 12060aagacgtttc ccgttgaata tggctcataa caccccttgt attactgttt atgtaagcag 12060
acagttttat tgttcatgat gatatatttt tatcttgtgc aatgtaacat cagagatttt 12120acagttttat tgttcatgat gatatatttt tatcttgtgc aatgtaacat cagagatttt 12120
gagacacaac gtggctttgt tgaataaatc gaacttttgc tgagttgaag gatcagatca 12180gagacacaac gtggctttgt tgaataaatc gaacttttgc tgagttgaag gatcagatca 12180
cgcatcttcc cgacaacgca gaccgttccg tggcaaagca aaagttcaaa atcaccaact 12240cgcatcttcc cgacaacgca gaccgttccg tggcaaagca aaagttcaaa atcaccaact 12240
ggtccaccta caacaaagct ctcatcaacc gtggctccct cactttctgg ctggatgatg 12300ggtccaccta caacaaagct ctcatcaacc gtggctccct cactttctgg ctggatgatg 12300
gggcgattca ggcctggtat gagtcagcaa caccttcttc acgaggcaga cctcagcgct 12360gggcgattca ggcctggtat gagtcagcaa caccttcttc acgaggcaga cctcagcgct 12360
agcggagtgt atactggctt actatgttgg cactgatgag ggtgtcagtg aagtgcttca 12420agcggagtgt atactggctt actatgttgg cactgatgag ggtgtcagtg aagtgcttca 12420
tgtggcagga gaaaaaaggc tgcaccggtg cgtcagcaga atatgtgata caggatatat 12480tgtggcagga gaaaaaaggc tgcaccggtg cgtcagcaga atatgtgata caggatatat 12480
tccgcttcct cgctcactga ctcgctacgc tcggtcgttc gactgcggcg agcggaaatg 12540tccgcttcct cgctcactga ctcgctacgc tcggtcgttc gactgcggcg agcggaaatg 12540
gcttacgaac ggggcggaga tttcctggaa gatgccagga agatacttaa cagggaagtg 12600gcttacgaac ggggcggaga tttcctggaa gatgccagga agatacttaa cagggaagtg 12600
agagggccgc ggcaaagccg tttttccata ggctccgccc ccctgacaag catcacgaaa 12660agagggccgc ggcaaagccg tttttccata ggctccgccc ccctgacaag catcacgaaa 12660
tctgacgctc aaatcagtgg tggcgaaacc cgacaggact ataaagatac caggcgtttc 12720tctgacgctc aaatcagtgg tggcgaaacc cgacaggact ataaagatac caggcgtttc 12720
ccctggcggc tccctcgtgc gctctcctgt tcctgccttt cggtttaccg gtgtcattcc 12780ccctggcggc tccctcgtgc gctctcctgt tcctgccttt cggtttaccg gtgtcattcc 12780
gctgttatgg ccgcgtttgt ctcattccac gcctgacact cagttccggg taggcagttc 12840gctgttatgg ccgcgtttgt ctcattccac gcctgacact cagttccggg taggcagttc 12840
gctccaagct ggactgtatg cacgaacccc ccgttcagtc cgaccgctgc gccttatccg 12900gctccaagct ggactgtatg cacgaacccc ccgttcagtc cgaccgctgc gccttatccg 12900
gtaactatcg tcttgagtcc aacccggaaa gacatgcaaa agcaccactg gcagcagcca 12960gtaactatcg tcttgagtcc aacccggaaa gacatgcaaa agcaccactg gcagcagcca 12960
ctggtaattg atttagagga gttagtcttg aagtcatgcg ccggttaagg ctaaactgaa 13020ctggtaattg atttagagga gttagtcttg aagtcatgcg ccggttaagg ctaaactgaa 13020
aggacaagtt ttggtgactg cgctcctcca agccagttac ctcggttcaa agagttggta 13080aggacaagtt ttggtgactg cgctcctcca agccagttac ctcggttcaa agagttggta 13080
gctcagagaa ccttcgaaaa accgccctgc aaggcggttt tttcgttttc agagcaagag 13140gctcagagaa ccttcgaaaa accgccctgc aaggcggttt tttcgttttc agagcaagag 13140
attacgcgca gaccaaaacg atctcaagaa gatcatctta ttaaggggtc tgacgctcag 13200attacgcgca gaccaaaacg atctcaagaa gatcatctta ttaaggggtc tgacgctcag 13200
tggaacgaaa actcacgtta agggattttg gtcatgagat tatcaaaaag gatcttcacc 13260tggaacgaaa actcacgtta agggattttg gtcatgagat tatcaaaaag gatcttcacc 13260
tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact 13320tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact 13320
tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt 13380tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt 13380
cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta 13440cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta 13440
ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta 13500ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta 13500
tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc 13560tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc 13560
gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat 13620gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat 13620
agtttgcgca acgttgttgc cattgctgca ggcatcgtgg tgtcacgctc gtcgtttggt 13680agtttgcgca acgttgttgc cattgctgca ggcatcgtgg tgtcacgctc gtcgtttggt 13680
atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg 13740atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg 13740
tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca 13800tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca 13800
gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta 13860gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta 13860
agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg 13920agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg 13920
cgaccgagtt gctcttgccc ggcgtcaaca cgggataata ccgcgccaca tagcagaact 13980cgaccgagtt gctcttgccc ggcgtcaaca cgggataata ccgcgccaca tagcagaact 13980
ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg 14040ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg 14040
ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt 14100ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt 14100
actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga 14160actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga 14160
ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc 14220ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc 14220
atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa 14280atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa 14280
caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgt 14327caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgt 14327
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110533162.1A CN113215117B (en) | 2021-05-17 | 2021-05-17 | Duck tembusu virus attenuated live vaccine candidate strain and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110533162.1A CN113215117B (en) | 2021-05-17 | 2021-05-17 | Duck tembusu virus attenuated live vaccine candidate strain and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113215117A CN113215117A (en) | 2021-08-06 |
CN113215117B true CN113215117B (en) | 2022-09-06 |
Family
ID=77092302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110533162.1A Active CN113215117B (en) | 2021-05-17 | 2021-05-17 | Duck tembusu virus attenuated live vaccine candidate strain and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113215117B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114015723B (en) * | 2021-11-05 | 2023-06-13 | 四川农业大学 | A duck Tembusu virus plasmid vector, attenuated strain and its preparation method and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002066621A1 (en) * | 2001-02-21 | 2002-08-29 | Heinz Franz X | Attenuated live vaccine |
CN101970467A (en) * | 2008-02-08 | 2011-02-09 | 英特塞尔股份公司 | Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
WO2017056094A1 (en) * | 2015-09-30 | 2017-04-06 | Ramot At Tel-Aviv University Ltd. | Attenuated virus mutated at sites of evolutionarily conserved rna structure |
CN109402172A (en) * | 2018-11-23 | 2019-03-01 | 四川农业大学 | A kind of preparation method of duck Tan Busu reporter virus and products thereof and application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106520710B (en) * | 2016-11-28 | 2020-01-14 | 广东省农业科学院动物卫生研究所 | Preparation and application of recombinant Newcastle disease virus live vector vaccine expressing duck tembusu virus prm and E proteins |
CN107937438B (en) * | 2017-11-29 | 2021-03-16 | 四川农业大学 | Transient transfection replicon of duck Tembusu virus carrying Renilla luciferase and its construction method and application |
-
2021
- 2021-05-17 CN CN202110533162.1A patent/CN113215117B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002066621A1 (en) * | 2001-02-21 | 2002-08-29 | Heinz Franz X | Attenuated live vaccine |
CN101970467A (en) * | 2008-02-08 | 2011-02-09 | 英特塞尔股份公司 | Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
WO2017056094A1 (en) * | 2015-09-30 | 2017-04-06 | Ramot At Tel-Aviv University Ltd. | Attenuated virus mutated at sites of evolutionarily conserved rna structure |
CN109402172A (en) * | 2018-11-23 | 2019-03-01 | 四川农业大学 | A kind of preparation method of duck Tan Busu reporter virus and products thereof and application |
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
CN113215117A (en) | 2021-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Erasmus et al. | A chikungunya fever vaccine utilizing an insect-specific virus platform | |
Pinschewer et al. | Kinetics of protective antibodies are determined by the viral surface antigen | |
Caley et al. | Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector | |
Klingmüller et al. | Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor | |
JP2021182922A (en) | Vaccine against hepatitis B virus | |
CN1810961B (en) | Recombinant influenza virus and its preparation and application | |
KR101229202B1 (en) | Multi plasmid system for the production of influenza virus | |
Yewdell et al. | Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. | |
CN107074913B (en) | Dengue virus chimeric polyepitope comprising fragments of non-structural proteins and uses thereof | |
CN113493855B (en) | Kit for detecting HBV cccDNA based on RAA-CRISPR-cas13a | |
NZ263680A (en) | Dna sequence encoding an influenza gene and vaccine therefrom | |
Pons | The inhibition of influenza virus RNA synthesis by actinomycin D and cycloheximide | |
Cole et al. | Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. | |
JP2003516732A5 (en) | ||
CN113215117B (en) | Duck tembusu virus attenuated live vaccine candidate strain and preparation method and application thereof | |
AU2021269903A1 (en) | Recombinant vaccine against covid-19 based on a paramyxovirus viral vector | |
CN107988174A (en) | A kind of rabies-canine distemper-the strain of canine parvovirus gene recombined virus, construction method and its application | |
CN115867561A (en) | Expression of SARS-CoV proteins, nucleic acid constructs, virus-like proteins (VLPs), and methods related thereto | |
JP2000154152A (en) | Therapeutic agent for hepatitis | |
CN114959107A (en) | Kit for detecting hepatitis B virus DNA based on RAA-CRISPR-Cas13a technology | |
CN112891336A (en) | Medical application of gallocatechin gallate and derivatives thereof | |
CN101020064A (en) | Brucellosis nucleic acid vaccine | |
CN101712965A (en) | Japanese encephalitis virus JEV replicon vector and application thereof | |
CN114959110A (en) | Kit for detecting hepatitis B virus pregenomic RNA based on PCR-CRISPR-Cas13a | |
CN114015723B (en) | A duck Tembusu virus plasmid vector, attenuated strain and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |